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Abstract 
 
The oxidation of lipids and antioxidants has been extensively studied in human 
plasma but little attention has been given to how plasma proteins are oxidised. 
Proteins make up the majority of biomolecules in cells and plasma and therefore are 
the most likely reactants with oxidants and free radicals. Previous studies in the 
laboratory had shown that peroxyl radicals generated by the thermolytic decay of 2-
azobis (2-amdinopropane) dihydrochloride (AAPH) generated significant amounts of 
protein hydroperoxides, but only after a six hour lag period.  In this study the 
existence of the six hour lag period was confirmed and shown by dialysis of the 
plasma to be due to the presence of low molecular weight antioxidants. The addition 
of both uric acid and ascorbic acid to the dialysed plasma restored the lag phase 
suggesting that in vivo these antioxidants act to prevent protein hydroperoxide 
formation. Lipid oxidation was also observed in the plasma but only after a two hour 
lag phase. This was the first time lipid oxidation has been observed in the absence of 
protein oxidation. The lipid lag phase was also abolished by dialysis of the plasma and 
restored by the addition of ascorbic acid and uric acid. The kinetics of tocopherol loss 
suggests that the tocopherol radicals act to inhibit lipid oxidation by transferring the 
electrons to the water-soluble ascorbate. The loss of ascorbate appears to cause the 
formation of a tocopherol radical mediate the lipid peroxidation process.  Overall the 
data shows ascorbic acid scavenging the peroxyl radicals while uric acid acts to 
reduce the overall AAPH generated radical flux.   
In a separate investigation, the production of protein-bound DOPA (PB-
DOPA) on albumin during X-ray radiolysis and copper mediate Fenton oxidation was 
investigated using a fluorescence based derivatisation method (ED-DOPA), which 
was compared with the more specific acid hydrolysis and HPLC analysis method.  
The ED-DOPA method consistently gave a much higher reading that the HPLC based 
methods, suggesting that the ED-DOPA method was measuring DOPA plus DOPA 
oxidation products. This was confirmed by oxidising X-ray radiolysis generated PB-
DOPA with Cu++ to cause DOPA oxidation. The Cu++ treatment drastically increased 
the level of signal given by the ED-DOPA assay while HPLC analysis showed all the 
DOPA had been oxidised. 
 
Chapter 1 1
INTRODUCTION 
 
 
1.1 Overview 
 
When there is an over production of free radicals, the balance of oxidants and 
reductants is disrupted.  This causes the level of free radicals to exceed the capacity of 
the antioxidants, which leads to oxidative stress.  Once formed, free radicals can 
induce the oxidative damage to a range of biomolecules, with the most important 
targets being lipids, proteins and DNA.  It has only recently been determined that 
proteins are most likely the primary target molecule of free radicals, with the reactive 
protein peroxyl radicals and hydroperoxide formation resulting from this reaction.  
These products are able to cause damage to other proteins, cross-link DNA, consume 
antioxidants, and damage lipids (Gebicki et al., 2000a; Gebicki, 1997).  Oxidative 
stress is thought to be the initiating factor in the pathologies of various diseases 
including cancer, atherosclerosis and diabetes (Granot and Cohen, 2004; Karten, 
2000; Du and Gebicki, 2004; Yeum et al., 2003; Salvi et al., 2001; Ames et al., 1981; 
Suh et al., 2003; Gebicki et al., 2000a).   
 
Previous studies investigating the kinetics of oxidation have focussed on protein 
oxidation generated by irradiation-induced hydroxyl radicals (OH˙) and superoxide 
radicals (O2˙-), and lipid peroxidation using isolated LDL.  Research in this laboratory 
by Ling, (2004) and Yang, (2005) has shown protein oxidation by water soluble 
peroxyl radicals in human blood plasma begins with a six hour lag phase where very 
few protein hydroperoxides (PrOOHs) form, followed by a rapid increase in 
formation.  The six hour lag phase is not present when dialysed plasma is exposed to 
peroxyl radicals, suggesting one or a number of small molecular weight antioxidants 
are involved in this protection.   
 
This study will examine the role of plasma antioxidants in controlling both lipid and 
protein oxidation in undiluted plasma exposed to peroxyl radicals, along with the 
activity of α-tocopherol under these same conditions. Antioxidants such as uric acid, 
ascorbic acid, and suggested sacrificial antioxidants like amino acids, will be 
investigated for their role in the protection of plasma proteins and lipids exposed to 
peroxyl radicals.  This study will also measure the formation of 3,4-
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dihydroxyphenylalanine (DOPA) on pure proteins exposed to radiation and Fenton 
radicals.  It will also investigate the effectiveness of the specific fluorescence assay in 
detecting PB-DOPA compared to the old but more reliable HPLC method. 
 
1.2 Free radicals  
 
A ‘free radical’ is described as a molecular chemical species containing one or more 
unpaired electrons.  These unpaired electrons make the molecule very unstable, 
therefore short lived and extremely reactive, with a tendency to extract an electron 
from a neighbouring molecule in order to attain a lower energy level and gain stability 
(Cheeseman et al., 1993; Morgan et al., 2004).   
 
The most significant free radicals in biological systems are derived from oxygen, 
assigning oxygen and its derivatives (superoxide and hydroxyl radical) as the most 
important reactants in the biological system.  Oxygen is the most abundant molecule 
in the biological system and exists as a di-radical that can react rapidly with other 
radicals (Karten, 2000).  With free radicals oxygen reacts rapidly, but the reaction 
with non-radical species is slow (Cheeseman et al., 1993; Davies and Delsignore, 
1987).  When oxygen reacts with free radicals, it is reduced by the addition of a single 
electron producing a superoxide free radical anion (O2-˙), which is the radical that is 
generated under the widest range of conditions (Equation 1).   
                                
                    (1)        O2 + e ? O2-˙              
 
O2-˙ is relatively stable but can dismutate to produce hydrogen peroxide (H2O2) and 
molecular oxygen, either spontaneously or by the catalysis of superoxide dismutase 
(SOD) (reaction 2).  In most healthy situations, this superoxide anion undergoes 
dismutation by SOD to produce hydrogen peroxide, which is broken down to produce 
water.  However, the hydrogen peroxide can be reduced to form highly reactive and 
potent hydroxyl radicals (OH˙) via the metal catalysed Fenton reaction (reaction 3) 
(Byrne et al., 2003). 
                  
(2)       O2-˙ +  2H+ ?  H2O2  + O2      
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                   (3)        Fe2+/ Cu+ +  H2O2   ?   Fe3+/ Cu2+  +  OH˙  +  OH- 
 
The hydroxyl radical has a short half-life of approximately 10-9 s and is only able to 
react with molecules within a short distance of 6 nm from the site of production 
(Gebicki, 1997; Dean et al., 1997; Du and Gebicki, 2004).   Despite this short lifetime 
and limited reaction area, OH˙ is capable of oxidizing nearly all cell constituents 
causing substantial damage (Gebicki, 1997; Cheeseman et al., 1993; Morgan et al., 
2004; Chang et al., 2000; Blakeman et al., 1998; Nordberg et al., 2001; Granot and 
Cohen, 2004).   
 
1.2.1 Free radicals in vivo 
 
The human body is continuously exposed to radicals generated in biological systems 
as a result of normal cellular processes (enzymes, mitochondrial respiration and 
neutrophils) and also as a result of exposure to external agents (air pollutants, natural 
gasses, irradiation, chemicals and toxins) (Granot and Cohen, 2004; Frei et al., 1989; 
Luxford et al., 1999).  These oxidants all produce reactive oxygen species (ROS) that 
are formed and degraded by all aerobic organisms on a regular basis to generate the 
required concentrations for important processes like phagocytosis.  In unfavourable 
situations, over production can produce excessive quantities of ROS as by products of 
metabolism (Nordberg et al., 2001; Frei et al., 1989; Rodgers et al., 2004; Cheeseman 
et al., 1993; Davies et al., 1995; Yeum et al., 2003).  The overproduction of free 
radicals disrupts the balance of oxidants and reductants causing the ROS to exceed the 
capacity of antioxidants.  This increases the risk of biomolecules, including proteins, 
lipids and DNA, being attacked and leading to oxidative stress (Yeum et al., 2003; Du 
et al., 2004; Granot et al., 2004; Karten, 2000).  This reaction may cause structural 
modifications and damage to the cellular membranes and the cellular organization of 
the molecule (Nordberg et al., 2001; Davies et al., 1995; Ames et al., 1981).  In-depth 
studies have identified that oxidative stress caused by increased free radical formation 
may be responsible for the initiation and development of a number of pathological and 
debilitating conditions, including atherosclerosis, diabetes, Wilson’s disease, cancer, 
aging and hemochromatosis (Du and Gebicki, 2004; Yeum et al., 2003; Salvi et al., 
2001; Ames et al., 1981; Suh et al., 2003, Gebicki et al., 2000a). 
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1.3 Radical generation  
 
Investigating free radical-mediated reactions of physiological relevance requires a 
source of free radicals that is similar to those occurring in the body.  2,2-azobis (2-
amidinopropane) dihydrochloride (AAPH), X-ray radiolysis and the Fenton reaction 
are three well-known and popular radical generators.  
 
1.3.1 AAPH 
 
AAPH is an azo compound, which decomposes unimolecularly without enzymes or 
biotransformation to yield nitrogen and two carbon centred radicals (reaction 15).  
The carbon radicals are formed in pairs in close proximity, with some joining to form 
a stable product.  However, most diffuse and react with oxygen molecules forming 
peroxyl radicals in the aqueous region (reaction 16).  When incubated at 37˚C the 
half-life is around 175 hours, so for the first few hours the rate of radical generation is 
relatively constant at 3.19 x 10-7 Ms-1 (Niki, 1990). This constant rate makes AAPH a 
useful tool in studying the damage caused by peroxyl radicals. 
 
AAPH has been used to generate oxidation products on both proteins and lipids, with 
protein hydroperoxides observed on pure proteins (Gebicki and Gebicki, 1993; Platt 
and Gieseg, 2003), plasma (Ling, 2004; Yang, 2005), U937 cells (Gieseg et al., 2000) 
and low density lipoprotein (LDL) exposed to peroxyl radicals generated by AAPH 
(Gieseg et al., 2003).  
 
                   (15)        R-C-N=N-C-R    →    R-C˙  +  N2  +  ˙C-R  
 
                   (16)        R-C˙  +  O2  →  R-COO˙ 
 
1.3.2 X-ray radiolysis 
 
X-ray radiolysis is another means of radical production used in the investigation of 
protein oxidation.  Many researchers have irradiated proteins in an attempt to study 
the products formed on proteins under such conditions.  X-ray radiolysis generates 
high numbers of free radicals by exciting water molecules (Halliwell and Gutteridge, 
1990).  This excitation causes the water molecules to split into a number of primary 
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species which, under aerobic conditions, go on to react with oxygen producing further 
radicals (reaction 17).   
 
(17)        H2O ?  ˙OH   +   e-aq   +   H˙  
                                ↓          ↓            ↓ 
                             H2O2      O2˙-       HO2˙- 
                                            ↓             ↓ 
                                         H2O2    H+ + O2˙- 
 
X-ray radiation of pure proteins in the presence of constant oxygenation is capable of 
oxidizing tyrosine residues to DOPA residues (Cudina and Josimovic, 1987; Parkes, 
2005).   X-ray radiation also produces PrOOHs on proteins exposed to irradiation. 
 
1.3.3 Fenton reaction 
 
Oxidative damage by free radicals in biological systems is often linked to the Fenton 
reaction.  The Fenton reaction is the one electron reduction of hydrogen peroxide 
(H2O2) by the transition metal ions, iron and copper (reaction 3).  Both iron and 
copper have been used as the transition metals when investigating the Fenton reaction 
however, it has been thought that the concentration of copper in vivo is too low for 
significant involvement.  It can also be rendered inert by its ligation to thiols, often 
making iron the more favourable transition metal.  (Kehrer, 2000; Koppenol, 2001).   
The Fenton reaction is another way of producing free radicals in experimental settings 
but not at a known rate.   
 
 
 
1.4 Protein oxidation 
 
Early investigations identified the main free radical targets as lipids and DNA.  
Proteins were simply described as antioxidants, protecting against oxidative stress by 
scavenging ROS and binding metal ions to inhibit the formation of HO˙ from H2O2 
(Gebicki et al., 2000a).  The major reaction occurring from free radical attack is now 
thought to be between proteins and free radicals.  This is due to their abundance in the 
cell, their ability to bind transition metal ions, and their high rate constants for 
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reactions as they readily react with biologically significant ROS undergoing extensive 
oxidation (Davies, 2003; Gebicki, 1997; Gebicki et al., 2000a &b; Gieseg et al., 2000; 
Morgan et al., 2004; Luxford et al., 1999; Du et al., 2004).   
 
The interaction of free radicals with proteins results in the alteration of the protein 
structure. This alteration occurs from the modification of amino acid side chains, 
protein fragmentation and DNA cross linking (Gebicki and Gebicki, 1999), which can 
lead to a loss of biological function, as well as increased susceptibility to proteolysis 
and heat denaturation (Rodgers et al., 2004).  It has been suggested that ROS species 
first damage a target molecule and, if the molecule is important in the survival of the 
cell, it undergoes apoptosis or is transformed.  The more probable event is that the 
first molecule attacked is converted to a secondary free radical or reactive 
intermediate, which goes on to generate more reactive species (Gebicki, 1997).  The 
oxidation of proteins by free radicals and ROS can generate a range of stable and 
reactive products, with the two major reactive products being protein hydroperoxides 
and protein bound DOPA (PB-DOPA) (Simpson et al., 1992; Dean et al., 1997; Fu et 
al., 1998, 1995; Luxford et al., 1999).  The former is an oxidising spcies while the 
latter is areducing species.  These reactive products have been associated with 
diseases such as Alzeimer’s, diabetes, atherosclerosis and aging (Du and Gebicki, 
2004; Yeum et al., 2003; Salvi et al., 2001; Ames et al., 1981; Suh et al., 2003, 
Gebicki et al., 2000a). 
1.4.1 Protein hydroperoxides  
 
One of the reactive but non-radical moieties produced as a consequence of the 
reaction between ROS and proteins is hydroperoxides.  Hydroperoxide groups form 
mainly on amino acids that possess secondary or tertiary carbons, giving the amino 
acid radical sufficient stability to form hydroperoxide groups in the presence of 
oxygen.  Hydroperoxide groups can alternatively form on the α-carbon backbone 
(Gebicki, 1997; Simpson et al., 1992; Gebicki and Gebicki, 1993).  PrOOHs are 
relatively stable and have a long lifetime, enabling them to diffuse large distances 
within cells and tissues.  Although relatively stable, hydroperoxides are still able to 
cause considerable damage by consuming antioxidants, inactivating enzymes, and 
causing DNA crosslinking.  In the presence of transition metal ions PrOOHs can be 
decomposed to produce secondary radical intermediates, which go on to produce 
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more radicals and further damage (Dean et al., 1997; Gebicki, 1997; Dean et al., 
1997; Gieseg et al., 2000; Du and Gebicki, 2004; Gieseg et al., 2003). 
 
PrOOH formation starts with a free radical (R˙) extracting a hydrogen atom to 
produce a carbon-centred radical (Pr˙) (reaction 4), which in the presence of oxygen, 
is converted to a protein peroxyl radical (PrOO˙) (reaction 5, 6).  This PrOO˙ is 
stabilized to PrOOH under reducing conditions (reaction 7).  The PrOO˙ could 
alternatively extract a hydrogen atom and electron from the side chain of another 
protein to form PrOOH and a new carbon-centred radical (reaction 8) that is thought 
to start the reaction over again (Neuzil et al., 1993), although reaction 8 has not been 
fully demonstrated. 
 
                   (4)        PrH + R˙ ? Pr˙  + RH                       
 
                   (5)        Pr˙ + O2 ? PrOO˙                                            
 
                   (6)        Pr˙ + e ? PrOO-                                                    
 
                   (7)        PrOO˙ + H+ ? PrOOH                                      
                                                                                                           
                   (8)        PrOO˙ + PrH ? PrOOH + Pr˙ 
 
Protein hydroperoxide formation on proteins can be measured by the Ferric-Xylenol 
Orange (FOX) assay.  The original assay was developed by S.P Wolff for lipid 
hydroperoxides (Wolff, 1994) and later modified by Gebicki for the measurement of 
protein hydroperoxides on proteins.  This modification was achieved by the removal 
of AAPH and the isolation of protein by precipitation with acid before measuring the 
absorbance of PrOOHs (Gay et al., 1999a, b and c).  The adapted FOX assay 
measures the amount of PrOOHs formed on proteins based on the ability of PrOOHs 
to oxidize ferrous ions (Fe2+) to ferric ions (Fe3+) (reaction 9).  The resulting ferric ion 
reacts with xylenol orange, forming a coloured complex (reaction 10) with an 
absorbance that can be measured at 560 nm on a spectrophotometer (Gay et al., 1999 
a and b).   
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                   (9)           PrOOH +  Fe2+    →   PrO˙ +  OH-  +  Fe3+                         
 
                   (10)          Fe3+ + XO  →  Fe −XO complex                                              
 
1.5 Plasma oxidation 
 
The kinetics of protein and lipid oxidation has in the past, been investigated on pure 
proteins and isolated LDL.  This has shown that protein hydroperoxides are produced 
on pure proteins while both protein and lipid hydroperoxides form on isolated LDL 
(Esterbauer et al., 1989).  Gieseg et al., (2003) identified PrOOHs on LDL exposed to 
copper, and THP-1 macrophages exposed to AAPH.  Pure protein oxidation was 
investigated using BSA solutions exposed to X-ray radiolysis and demonstrated that 
ROS formed from radiation could generate PrOOHs in a linear fashion, but only in the 
presence of oxygen (Simpson et al., 1992; Neuzil et al., 1993; Platt and Gieseg, 
2003).  While investigating the formation of PrOOHs in human blood serum exposed 
to hydroxyl radicals, Gebicki et al., 2000a showed that PrOOHs could be detected in 
human plasma proteins with no detectable lag phase.  Furthermore ascorbate did not 
protect against OH˙ attack in the plasma.  It was suggested that the attack of OH˙ on 
proteins could result in the formation of reactive protein peroxyl radicals and 
hydroperoxides that are able to damage other proteins, DNA, antioxidants, and lipids.  
Also, proteins may constitute an early and vital step in the transmission of ROS-
mediated biological damage induced by acquiring chemically reactive moieties, which 
can act as new sources of damage to all components.  Ling, (2004) and Yang, (2005) 
further investigated the formation of PrOOHs in human blood plasma by exposure to 
peroxyl radicals.  In this system, a six hour lag phase was observed where very little 
PrOOHs were formed, followed by a rapid increase in formation.  Dialysed plasma 
exposed to peroxyl radicals removed this lag phase, indicating that a small molecular 
weight antioxidant is protecting the plasma proteins during the first six hours of 
oxidation.  Lipid peroxidation in human blood plasma exposed to peroxyl radicals 
begins with a lag phase where no or very few lipid hydroperoxides formed during the 
first 50-60 minutes, followed by a linear increase in formation post-lag phase 
(Thomas et al., 1997; Neuzil et al., 1993; Frei et al., 1988; Esterbauer et al., 1989).  
The lag phase coincides with ascorbic acid depletion; once ascorbic acid is consumed 
lipid oxidation occurs.  The fact that the AAPH-induced kinetics of both lipid and 
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protein oxidation begin with lag phases suggests the processes are connected, with an 
antioxidant causing the lag phases in both processes. 
 
1.6 Lipid oxidation 
 
Lipid oxidation is a process occurring when the double bond in polyunsaturated fatty 
acids (PUFAs) is attacked by free radicals.   The reaction proceeds by the removal of 
a hydrogen atom from the PUFA (LH) by a radical (R˙), generating a fatty acid 
radical (L˙) (reaction 11).  The resulting fatty acid radical can readily, and rapidly, 
react with oxygen to form a fatty acid peroxyl radical (LOO˙) (reaction 12).  Adjacent 
unsaturated fatty acids (L’H) will be attacked by this LOO˙, promoting further 
oxidative damage to lipids.  Oxidation is, therefore, a self-propagating chain reaction 
that can lead to the formation of lipid hydroperoxides (LOOHs).  The termination of 
this reaction occurs when fatty acid radicals react with each other, or with endogenous 
antioxidants, producing non-radical products (reaction 13) (Kehrer, 2000).  Further 
oxidation of the lipid hydroperoxide causes the production of a variety of highly 
reactive secondary products, mainly short-chained aldehydes (reaction 14).  These 
aldehydes can react with apolipoproteins so that the lipoprotein recognition by 
receptors for native lipoproteins is hindered.  The lipoprotein oxidation can be 
inhibited by several antioxidants, which scavenge free radicals and form more stable 
products (Karten et al., 1997).  
                   (11)        Initiation           LH  +  R˙  →  L˙  +  RH 
 
                   (12)        Propagation      L˙  +  O2  →  LOO˙ 
                                                           LOO˙  +  L’H  →  LOOH  + L’˙ 
 
                   (13)        Termination      LOO˙  +  LOO˙  →  Non-radical product 
 
                   (14)                                  LOOH  --------------->  LO˙,  LOO˙, aldehydes  
 
Carbon-centred radicals such as the lipid radical (L˙) can be stabilised by molecular 
rearrangement to form a conjugated diene.  The formation of conjugated dienes is an 
indicator of lipid oxidation and can be observed by measuring the absorbance at 234 
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nm (Esterbauer et al., 1989; Kritharides et al., 1993; Halliwell and Gutteridge, 1999).  
Lipid oxidation occurs in three distinct steps, starting with a lag phase where little or 
no lipid oxidation occurs and followed by a propagation phase of increasing lipid 
oxidation.  The third and final phase shows a decrease in lipid oxidation products and 
is caused by more products being degraded than formed.  Lipid oxidation leads to the 
modification of LDL, causing the modified LDL to be susceptible to increased uptake 
by the scavenger receptor of macrophage cells (Esterbauer et al., 1989).   
 
1.7 The antioxidant defence system 
 
The human body has adapted itself to living with a constant efflux of ROS.  The most 
important mechanism in plasma is the antioxidant defence system, with antioxidants 
either synthesized in our bodies or consumed through our diet (Granot and Cohen, 
2004).  However, oxygen-based reactants that escape detoxification by cellular 
antioxidant systems are responsible for an estimated 10,000 DNA base modifications 
per cell per day.  This clearly illustrates that the mechanisms for protecting the body 
from harmful oxidants is not perfect (Mayo et al., 2003). 
 
An antioxidant is described as ‘a substance that when present in low concentrations 
compared to that of an oxidizable substrate, prevents or delays the oxidation of the 
substrate’ (Halliwell, 1988; Santos et al., 1999).  The antioxidants synthesized in our 
bodies include all antioxidant proteins and various small molecules (Frei et al., 1989).  
Due to the existence of a wide variety of reactive oxygen species that produce damage 
to target molecules at different locations, there are many different antioxidants and 
they can provide protection in a range of ways.  Preventative and chain-breaking 
antioxidant activities are just two examples.  To provide optimal protection from 
oxidants, antioxidants often work together as co-antioxidants, recycling each other or 
working in unison.  The most important plasma antioxidants are thought to be 
ascorbate, urate, α-tocopherol, bilirubin and albumin (Frei et al., 1988).   
 
1.7.1 α-Tocopherol (Vitamin E)  
 
α-Tocopherol (α-TOH) is the major lipid soluble antioxidant found in LDL present at 
a quantity of 6 molecules per lipoprotein (Terentis et al., 2002; Esterbauer et al., 
1992).  Its phyl side chain is required for incorporation and retainment in membranes 
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and lipoproteins (Upston et al., 2003).  α-Tocopherol has predominantly been 
described as a classical chain breaking antioxidant that protects LDL against lipid 
peroxidation by directly scavenging free radicals and reacting rapidly with the chain 
carrying lipid peroxyl radical (LOO·) to break propagation (Kontush et al., 1996; Niki 
et al., 2005; Thomas and Stocker, 1999; Bowry et al., 1992).  This occurs by α-
tocopherol donating its phenolic hydrogen to LOO·, creating a less reactive α–
tocopheroxyl radical (α-TO·) and LOOH.  It can, alternatively, react directly with the 
initiating radical oxidant to prevent LOO· formation, producing an inactive oxidant 
and an α-TO· radical (reaction 18).  The α-TO· radical that is formed can then be 
eliminated by a radical-radical reaction with another LOO·, generating non-radical 
products (reaction 19) (Upston and Stocker, 1994; Thomas and Stocker, 2000; Karten 
et al., 1997).  As α-TO· is free to diffuse in homogenous solutions and rapidly reacts 
with other radicals, these reactions lead to both the termination of the chain reaction 
and the consumption of α-tocopherol.  Furthermore, as α-TOH and α-TO· both 
scavenge radicals, each molecule of α-TOH can terminate two potential chain 
reactions (Thomas and Stocker, 2000).  
 
                    (18)   Inhibition       α-TOH + LOO·   ?  α-TO· + LOOH 
 
                                                    α-TOH + Radical oxidant ? inactive oxidant + α-TO· 
 
                    (19)  Termination   α-TO· + LOO·   ? LOOH + non-radical products 
 
The classical chain breaking antioxidant mechanism is proposed to occur when the 
radical flux is high.  Under high radical flux the concentration of LOO˙ is sufficiently 
high for the termination reaction to predominate, resulting in both the prevention of 
lipid peroxidation and rapid consumption of α-tocopherol (reaction 19).  By contrast, 
a low radical flux reduces the concentration of LOO˙, causing termination reactions to 
become infrequent.  This switch to a pro-oxidant state is described by the tocopherol-
mediated peroxidation (TMP) model (reaction 20). 
 
                    (20)        α-TO· + LH ? L· + α-TOH 
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The TMP model describes α-TOH acting as a phase transfer agent that reacts with 
aqueous radical oxidants (R·).  This results in the formation of α-TO· and therefore, 
the import of radicals from the aqueous into the lipid phase.  Additionally, α-TO· 
becomes trapped within the LDL and cannot undergo the radical-radical termination.  
Termination can now only occur when a second R· enters the oxidizing particle and 
reacts with the radical, stopping the reaction.  α-TO· can initiate lipid peroxidation by 
abstracting a hydrogen atom either from the surface or core lipids that contain bisallic 
hydrogens.  The resulting LOO· is scavenged rapidly by α-TOH to produce LOOH 
and a new α-TO·.  During AAPH-mediated oxidation, the albumin appears to 
scavenge so many ROO˙ that the concentration of LOO˙ is low and TMP 
predominates (Upston et al., 2003; Esterbauer et al., 1992; Upston et al., 1999).  
Although the TMP reaction occurs in the absence of other antioxidants, it can be 
inhibited by the presence of suitable co-antioxidants that can react with α-TO· (Upston 
et al., 2003; Stocker 1999; Upston et al., 1999; Thomas and Stocker, 2000).  This 
enables the regeneration of α-TOH and forms a co-antioxidant derived radical that 
exports the radical back into the aqueous phase to produce a non-radical product and 
stopping the reaction.  Ascorbate is the most well-known co-antioxidant for α-
tocopherol, while urate and β-carotene are not thought to act as co-antioxidants 
(Neuzil and Stocker, 1994).  
 
1.7.2 Ascorbic acid (Vitamin C) 
 
Ascorbic acid or, as it also known, vitamin C, is a potent water-soluble antioxidant in 
plasma.  It is a strong reducing agent with multiple antioxidant properties, ranging 
from the scavenging of various types of reactive oxygen species (superoxide and 
hydroxyl radicals) to the reduction of protein hydroperoxides that are formed.  It is 
also known to act as a co-antioxidant recycling the α-tocopheroxyl radical back to α-
tocopherol via donation of an electron (Mendiratta et al., 1997; Schafer et al., 2003; 
Retsky et al., 1993; Suh et al., 2003; Nieto et al., 2000; Gebicki et al., 2000b).  This 
proceeds by ascorbate undergoing two consecutive reversible one-electron oxidation 
reactions to form the ascorbate radical, dehydroascorbate (DHA).  The unpaired 
electron of this ascorbate radical is in a highly delocalized system, making the radical 
unreactive (Mendiratta et al., 1997; Schafer et al., 2003; Halliwell, 1990; Retsky et 
al., 1993; Stait et al., 1994).   
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The pattern of lipid oxidation has also been linked to the presence of ascorbic acid.  
Plasma lipids have been found to be oxidised by peroxyl radicals only after a lag 
phase during which ascorbic acid is depleted.  It has been suggested that ascorbic acid 
reacts with the initial product of protein oxidation product (PrOO˙) from the hydroxyl 
radical attack.  Once the ascorbic acid has been oxidized, and is no longer present in 
the plasma, the lipids are able to react with the protein radicals leading to lipid 
peroxidation (Gebicki et al., 2000a). 
 
Although ascorbic acid is an excellent antioxidant, it is also known to act as a pro-
oxidant in the presence of transition metal ions due to its reducing properties.  The 
process of ascorbate-mediated metal reduction further generates hydrogen peroxide, 
which is essential in the oxidation of many single state organic molecules (Retsky et 
al., 1993; Stait et al., 1994; Suh et al., 2003). 
 
1.7.3 Uric acid 
 
Uric acid is a water-soluble antioxidant present in the plasma as the monoanion urate 
(Nieto et al., 2000).  It is found at much higher levels in humans than other primates 
due to the absence of an enzyme, urate oxidase, in human tissues.  In other primates, 
uric acid is broken down to allantoin and this along with urea is excreted as the major 
nitrogen containing products of purine degradation (Becker, 1993).  The absence of 
urate oxidase in human tissues has lead to the suggestion that uric acid is an important 
antioxidant for humans (Santos et al., 1999; Becker, 1993).  In support of this, the 
concentration of approximately 300-500 μM uric acid in plasma is higher than other 
non-enzymatic antioxidants.  A suggested ability to absorb 30-65% of the peroxyl 
radical scavenging capacity of plasma also suggests uric acid is a major radical 
scavenger in human plasma (Becker, 1993). 
 
The antioxidant property of uric acid arises from its ability to directly scavenge free 
radicals and also by binding to transition metal ions in forms that do not accelerate 
free radical reactions (Schlott et al., 1998).  The ability of uric acid to chelate metal 
ions and react with potent biological oxidants, such as the hydroxyl radical and 
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hypochlorous acid, produces relatively stable products including allantoin and oxonic 
acid (Santos et al., 1999).   
 
Like ascorbic acid, uric acid has also been suggested to possess pro-oxidant properties 
due to reactions with hydroxyl or peroxyl radicals, thereby generating uric acid 
radicals that can cause damage.  The one electron oxidation of urate produces a urate 
radical anion, which is relatively stable and does not react with oxygen (reaction 20).  
The anion can, however, react with a weaker oxidant like ascorbate, regenerating 
urate and producing an ascorbate radical (reaction 21), this is known as ascorbate-
urate redox cycling.  Conversely, when ascorbic acid is not present, urate is oxidized 
to allantoin (Halliwell, 1990; Becker, 1993).   
                  
                  (20)         OH˙ + U- --> OH- + U˙                                Urate oxidation 
 
                   (21)         U˙ + Asc- --> U- + Asc˙                               Ascorbate oxidation 
 
1.7.4. Amino acids 
 
Some molecules while not recognized as classical antioxidants, are able to intercept 
the reaction between target molecules and oxidants.  These molecules are known as 
sacrificial antioxidants, acting  as antioxidants only in these situations.  Free amino 
acids are theorized to serve  as sacrificial antioxidants in the protection of plasma 
proteins (Halliwell, 1989).   
 
 Free amino acids in human plasma are highly susceptible to oxidative attack by ROS 
formed as by-products of metabolism, pollutants in the atmosphere, or radiation 
(Stadtman and Levine, 2003).  Valine, leucine, isoleucine, proline, and glutamine are 
the amino acids found to produce the highest levels of peroxides, with valine being 
the amino acid on which hydroperoxides are formed most favourably under radical 
attack (Fu et al., 1995; Soszynski et al., 1995; Davies et al., 1995; Gebicki et al., 
1995).  These peroxides are known to be relatively stable, but in the presence of 
biological reductants or metal ions, they are decomposed to reactive free radicals, 
causing further damage (Soszynski et al., 1995; Luxford et al., 1999).  The ability of 
amino acids to react with OH˙ or ROO˙ and form peroxides could potentially 
influence protein synthesis because a change in protein metabolism results in 
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modifications to the plasma free amino acid profile.  This indicates that free amino 
acid levels are good indicators of protein metabolism and nutritional status (Wu et al., 
1998; Muscaritoli et al., 1998; Chuang et al., 2006).  Significant differences in free 
amino acid levels have been found between untreated arthritis patients and normal 
individuals; in workers in stressful environments compared to workers in less stressful 
environments (Borden et al., 1952; Wu et al 1998).   
 
1.8 PB-DOPA 
 
Two classes of protein bound reactive oxygen species exist when proteins are exposed 
to hydroxyl radicals and metal-dependent Fenton systems.  These classes are PrOOHs 
and PB-DOPA (Fu et al., 1998; Gieseg et al., 1993).  PB-DOPA is the major reducing 
species produced by hydroxyl radical attack on tyrosine residues, and it is one of the 
major oxidized species elevated in pathological tissues (Rodgers et al., 2004; Gieseg 
et al., 1993; Luxford et al., 1999; Jain et al., 1997).   
 
DOPA formation from tyrosine can occur via two non-enzymatic pathways, one in the 
presence of oxygen (O2), and the other in the absence of O2.  When O2 is absent, the 
pathway occurs via the elimination of two OH˙ radicals in a disproportion reaction.  
This requires two tyrosine molecules and forms both tyrosine and DOPA.  By 
contrast, the presence of O2 promotes a higher yield of PB-DOPA.  A third pathway 
for PB-DOPA formation is enzymatic and involves tyrosine catalysing the conversion 
of tyrosine residues to DOPA (Ito et al., 1984).  PB-DOPA may also form when the 
free amino acid DOPA becomes incorporated into proteins (Rodgers et al, 2002).  It is 
a stable molecule, allowing it to cause damage away from the site of formation 
(Rodgers et al., 2004; Gieseg et al., 1993; Luxford et al., 1999).   
 
By using the acid hydrolysis of proteins followed by the separation of the 
hydrolysates via high performance liquid chromatography (HPLC), Gieseg et al., 
(1993) originally described the detection of PB-DOPA formation.  The method is 
specific for measuring PB-DOPA but very time consuming.  A new method was later 
proposed by Armstrong and Dean, (1995) using ethylenediamine (ED) to derivatise 
free catecholamines.  The reaction involves condensation between ED and the two 
carbonyls of o-benzoquinones that are formed upon oxidation.  After incubation with 
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ethylenediamine, the fluorescence of the ED-DOPA derivative is measured on a 
spectrophotometer.  Parkes, (2005) adapted the method proposed by Armstrong and 
Dean, (1995), noting the fluorescence intensity of PB-DOPA reached a maximum at 
an emission of 430 nm and an excitation of 545 nm.  Further, an incubation period of 
60 minutes was shown to be optimal.  
 
1.9 Objectives of study 
 
Most investigations have examined PrOOHs only on pure proteins (Simpson et al., 
1992; Gebicki et al., 2000a and b; Gay and Gebicki, 2003; Gieseg et al., 2000; 
Gebicki and Gebicki, 1993).  More recently, however, Gebicki et al., (2000a) 
investigated the hydroxyl radical-induced formation of PrOOHs in human blood 
serum and noted their immediate production.  The lack of an observable lag phase 
contrasted with the existence of a lag phase for lipid oxidation.  A similar PrOOH 
trend was observed by Gieseg et al., (2000) when exposing U937 cells to AAPH-
derived peroxyl radicals.  Radical-induced lipid oxidation has also been 
predominantly investigated using only pure lipid substrates.  Very little or no lipid 
hydroperoxides are formed over the first 60 minutes, which is followed by a rapid 
linear increase in formation (Thomas et al., 1997; Neuzil et al., 1993; Frei et al., 
1988).   
 
Although the human body possesses an exceptional defence system, it is unable to 
completely protect plasma from protein and lipid oxidation.  PrOOHs and lipid 
hydroperoxides are known to form when exposed to hydroxyl and peroxyl radicals, 
with lipid hydroperoxide formation occurring only after the complete consumption of 
the antioxidant ascorbate.  α-Tocopherol and uric acid also act as antioxidants in this 
system, lowering the rate of lipid peroxidation by scavenging chain-propagating 
peroxyl radicals (Gebicki et al., 2000a; Frei et al., 1989; Suarna et al., 1995; Stocker 
et al., 1991).  Previous research in the laboratory has demonstrated a six hour lag 
phase during peroxyl radical-mediated PrOOH formation in whole human plasma.  
The inhibition does not appear to be caused by α-tocopherol, thiols or glutathione 
(Ling, 2004; Yang, 2005).  Although, uric and ascorbic acid contributed to the 
inhibition, they could not separately account for the entire lag phase.  This indicates 
that uric and ascorbic acid, combined may be responsible for the six hour lag phase.  
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The initiation of lipid oxidation has been found to coincide with the depletion of 
ascorbic acid; once ascorbic acid is consumed, lipid oxidation occurs.  The lag phases 
and the contribution of ascorbic acid to the inhibition of both lipid and protein 
oxidation suggests the processes are connected. 
 
As a continuation of Ling, (2004) and Yang, (2005’s) research, this study will 
examine the kinetics of PrOOH formation in human plasma during exposure to the 
peroxyl radical generator AAPH.  To identify the antioxidant responsible for the six 
hour lag phase during AAPH-induced human blood plasma oxidation, plasma will be 
dialysed to remove low molecular weight molecules.  Such molecules include 
ascorbic acid, uric acid and free amino acids.  These low molecular weight 
antioxidants will subsequently be added to the dialysed plasma in controlled 
quantities, and exposed to AAPH.  PrOOH formation in each treatment will then be 
measured in an attempt to isolate the source of the lag phase. 
 
This research will also examine the kinetics of cholesterol diene formation in human 
blood plasma when exposed to AAPH-derived peroxyl radicals. To understand the 
kinetics of CL diene formation further, plasma will be dialysed and supplemented 
with ascorbic and uric acid.  These are the antioxidants postulated to be involved in 
the inhibition of protein oxidation (Yang, 2005).  Supplemented plasma will be 
exposed to peroxyl radicals by incubation with AAPH.  α-Tocopherol loss will also be 
monitored to determine the significance of this antioxidant in protecting plasma from 
AAPH-induced oxidation.   
 
A final part of this thesis is distinct from the above research but aims to complete the 
work of Parkes, (2005) a former Master’s student in the Free Radical Biochemistry 
Laboratory.  As such, the concentration of irradiation-induced PB-DOPA will be 
measured on pure proteins by both the ED-DOPA assay and HPLC analysis.  BSA 
will also be exposed to a system simulating the Fenton reaction to examine whether 
PB-DOPA can be produced on a pure protein under these conditions.  The two PB-
DOPA assays will ultimately be compared to determine which one is best and whether 
the ED-DOPA assay is specific for PB-DOPA or also detects additional products. 
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MATERIALS AND METHODS 
 
2.1 Materials 
 
2.1.1 Chemicals 
 
All reagents used in the research were of analytical grade or better.  All water used 
was de-ionised and filtered by a nanopure ultra-filtration system supplied by 
Millipore, USA. 
 
α–Tocopherol                                                                                  Sigma Chemical Co., St. Louis, MO, USA 
2,2’-azobis (2-amidinopropane) dihydrochloride (AAPH) Arcos, NJ, USA 
L-3,4-dihydroxyphenylalanine (L-DOPA) Sigma Chemical Co. 
Acetic acid (glacial) Merck Ltd, Poole, England 
Acetonitrile Merck Ltd 
Alanine                                                                                            Sigma Chemical Co. 
Ammonium ferrous sulfate Hopkin and Williams Ltd, Essex 
Anhydrous sodium acetate BDH Chemicals Ltd 
Arginine                                                                                          Sigma Chemical Co. 
Argon gas BOC Gasses, New Zealand 
Ascorbate oxidase Sigma Chemical Co. 
Ascorbic acid Sigma Chemical Co. 
Bovine serum albumin (BSA) Sigma Chemical Co. 
Butylated hydroxytoluene (BHT) Sigma Chemical Co.   
Catalase Sigma Chemical Co. 
Chelex-100 resin Bio-Rad Laboratories, CA, USA 
Chloroform Merck Ltd and Univar 
Cholesteryl linoleate ester Sigma Chemical Co. 
Copper chloride BDH Chemicals Ltd 
Copper sulfate BDH Chemicals Ltd 
Diethyl ether BDH Chemicals Ltd 
Dodecyltrimethyl ammonium chloride Fluka 
Ethanol BDH Chemicals Ltd 
Ethylenediamine                                                                             Sigma Chemical Co. 
Ethylenediamine dihydrochloride                                                   Sigma Chemical Co. 
Ethylenediamine tetraacetic acid (EDTA)                                      BDH Chemicals Ltd 
Ethylenediaminetetraacetic acid disodium salt (Na2EDTA)           BDH Chemicals Ltd 
Glutamine                                                                                        Sigma Chemical Co. 
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Glycine                                                                                            Sigma Chemical Co. 
n-Hexane BDH Chemicals Ltd 
Histidine                                                                                          Sigma Chemical Co. 
Hydrochloric acid (HCl) BDH Chemicals Ltd 
Hydrogen peroxide BDH Chemicals Ltd 
Isoleucine                                                                                        Sigma Chemical Co. 
Isopropanol Merck Ltd 
Leucine                                                                                            Sigma Chemical Co. 
Lysine                                                                                              Sigma Chemical Co. 
Methanol Merck Ltd 
Mercaptoacetic acid (Thioglycolic acid) Sigma Chemical Co. 
Nitrogen gas BOC gasses 
Oxygen gas                                                                                      BOC gasses 
Phenol                                                                                              Sigma Chemical Co. 
Proline                                                                                             Sigma Chemical Co. 
Sodium chloride (NaCl) BDH Chemicals Ltd 
Sodium dihydrogen orthophosphate (NaH2PO4) BDH Chemicals Ltd 
Sodium hydroxide (NaOH) BDH Chemicals Ltd 
Sucrose Chelsea sugar refinery: Auckland, NZ 
Sulfuric acid (H2SO4) BDH Chemicals Ltd 
T-butyl methyl ether BDH Chemicals Ltd 
Toluene BDH Chemicals Ltd 
Trichloroacetic acid (TCA) Merck  Ltd  
Trifluoroacetic acid (TFA) Sigma Aldrech Chemical Co. 
Tyrosine                                                                                          Sigma Chemical Co. 
Uric acid Sigma Chemical Co. 
Uricase Sigma Chemical Co. 
Valine                                                                                              Sigma Chemical Co. 
Xylenol orange Sigma Aldrech Chemical Co. 
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2.1.2 Specialised solutions and buffers preparation 
 
A) Protein oxidation 
 
Phosphate buffered saline (PBS) 
PBS composed of 150 mM sodium chloride (NaCl) and 10mM sodium dihydrogen 
orthophosphate (NaH2PO4), at pH 7.4, was prepared from stock solutions.  Washed 
chelex-100 was added to the solution and left stirring overnight to remove any 
transition metals in the solution.  The chelex was removed the next day by filtration 
through a 0.22 μM filter.  The PBS was then sonicated in order to remove air bubbles 
and stored at 4˚C.  Prior to use, the PBS was warmed to room temperature. 
 
2,2’-azobis (2-methyl-propanamidine) dihydrochloride (AAPH) 
A stock solution of 250 mM was prepared on the day of the experiment by dissolving 
AAPH (MW 271.19 g/mol) in ice-cold PBS.  The stock solution was stored on ice 
until required. 
 
Bovine serum albumin (BSA) solutions 
A stock solution of 10 mg/ml was prepared on the day of the experiment by dissolving 
BSA in PBS.  Diluting the 10 mg/ml stock with PBS created various concentrations of 
BSA. 
 
B) Solutions for FOX assay 
 
Xylenol orange solution 
A 5 mM solution was composed by dissolving xylenol orange (MW 760.6 g/mol) in 
25 mM sulfuric acid (H2SO4).  The solution was stored at room temperature for up to 
one month. 
 
Ammonium ferrous sulfate 
A 5 mM solution was composed by dissolving ferrous ammonium sulfate (MW 
392.16) in 25 mM sulfuric acid (H2SO4).  The solution was stored at room 
temperature and used within one week. 
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Sulfuric acid  
A 1 mM stock solution of H2SO4 was composed by adding 5.4 ml of H2SO4 to 94.6 
ml of water. A 25 mM solution was made by dilution of 0.5 ml stock solution with 
19.5ml of water. 
 
TCA 
TCA was prepared at concentrations of 72% and 5% w/v in water. 
 
C) Antioxidants and amino acids 
 
Amino acids 
10 mM stock solutions of tyrosine, proline, leucine, isoleucine, arginine, histidine, 
glutamine, alanine, glycine, valine and lysine were prepared by dissolving the amino 
acid in 50 ml PBS. 
 
D) HPLC cholesterol diene analysis 
 
Butylated hydroxytoluene (BHT) 
A 20 mg/ml solution was prepared by dissolving BHT in methanol.  The solution was 
stored at 4˚C. 
 
Ethylenediamine-tetraacetc acid disodium salt (EDTA) 
A 100 mg/ml solution was prepared by dissolving EDTA in nanopure water.  The pH 
was adjusted to 7.4 by adding drops of 10 mM NaOH and then stored at 4˚C. 
 
Cholesteryl linoleate hydroperoxide standard 
20 mg of cholesterol linoleate ester was dissolved in 1 ml of toluene.  2 ml of 100 mM 
AAPH was added to the 15 ml black-top glass tube and incubated at 37 ˚C under 
constant mixing at 110 rpm for 24 hours.  The top toluene layer was transferred into a 
tapered test tube using a Pasteur pipette.  The layer was dried down under nitrogen in 
an oxygen-free water bath, reconstituted in 5 ml of hexane and then run through an 
aluminium oxide column.  10 ml of T-butyl methyl ether was run through the column 
and the cholesterol hydroperoxide (CL-OOH) was collected in a black-top glass 
centrifuge tube.  This was dried down again and reconstituted in 8 ml of 
acetonitrile/isopropanol (30:70).  The concentration was determined by its absorbance 
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at 234 nm using the extinction coefficient 29, 500 M-1cm-1 (Sattler et al., 1994).  After 
layering the tube with argon, it was kept in a -80 ˚C freezer until required. 
 
E) HPLC α-Tocopherol analysis 
 
α-Tocopherol standard 
A stock solution of 100 mM α-tocopherol was stored in the -20˚C freezer.  The stock 
solution was diluted to 10 μM with cold methanol and injected into the HPLC for α-
tocopherol analysis.    
 
F) ED-DOPA assay 
 
Ethylenediamine dihydrochloride 
A 2 M ethylenediamine dihydrochloride solution was prepared by dissolving 
ethylenediamine dihydrochloride in nanaopure water.  Sonication ensured all the 
ethylenediamine dihydrochloride was dissolved. 
 
Ethanol/Diethyl ether solution 
Ethanol and diethyl ether were mixed together in a ration of 3:1.  The solution was 
inverted to ensure the solutions had mixed. 
 
DOPA stock solutions 
A 1 mM solution of DOPA was prepared on the day of analysis by dissolving DOPA 
in nanopure water.  The solution was sonicated to allow the DOPA to dissolve and the 
solution was stored at 4˚C in the dark until required.  This stock solution was diluted 
to 50 μM with nanopure water.  DOPA standards, to concentrations of 0, 5, 10, 25, 
and 50 μM, were prepared from DOPA stock solutions and nanopure water.  
Standards were made up to a final volume of 500 μl. 
 
G) HPLC DOPA solutions and buffers 
 
6M HCl with 1% w/v phenol solution 
In a 50 ml solution of 6 M HCl, phenol was dissolved to a final concentration of 1% 
w/v.  
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Mobile phase 
A 1 litre 0.1% TFA solution was made up by adding 1ml TFA to 900 ml of nanopure 
water.  The pH was adjusted to pH 2.5 with of 10 mM HCl.  The volume was then 
made up to a final volume of 1 litre with nanopure water.  The solution was filtered 
through a 0.22 μM filter and sonicated for ten minutes to degas. 
 
H) HPLC determination of ascorbate and urate  
 
Mobile phase  
A 1 litre solution was made up by dissolving 3.28 g of sodium acetate anhydrous, 0.2 
g of Na2EDTA and 0.130 g of dodecyltrimethylammonium in 800 ml of nanopure 
water.  75 ml of methanol was added and the pH of the solution adjusted to 4.8 with 
glacial acetic acid.  Nanopure water was added to make a final volume of 1 litre.  The 
solution was filtered through a 0.22 μM filter and sonicated for 20 minutes to remove 
air bubbles. 
 
Sample preparation buffer 
A 10 mM solution was prepared by dissolving EDTA in 100 ml nanopure water.  To 
make a 90% methanol/water/1 mM EDTA buffer, 5 ml of the 10 mM EDTA solution 
was mixed with 45 ml of methanol. 
 
Ascorbic acid and uric acid standards 
2 mM stock solutions of ascorbic or uric acid were prepared by dissolving 4 mg of 
either antioxidant in nanopure water.  The stock solutions were diluted 1/200 to give a 
final concentration of 10 μM.  
 
2.2 Methods 
 
2.2.1 Blood collection and plasma preparation 
 
Blood was collected from volunteers by venipuncture using winged infusion sets and 
a 50 ml syringe (Terumo, USA).  The volunteers fasted overnight and were in a 
healthy condition.  200 ml was collected from each donor into four 50 ml centrifuge 
tubes containing 0.5 ml 10% ETDA (pH 7.4) as an anti coagulant. 
The tubes were centrifuged at 4100 g for 20 minutes at 4˚C with the brake off to 
separate the cells from the plasma.  The plasma was then transferred to 50 ml round 
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bottom centrifuge tubes and centrifuged at 11, 000 g for 30 minutes in a fixed angle 
rotor to remove the cellular components reminiscent in the plasma.  The plasma from 
four-six donors was pooled together and 50% sucrose solution was added to make a 
final concentration of 0.6%.  The plasma was stored in 20 ml aliquots in the -80 
freezer for up to three months until required. 
 
2.2.2 Plasma and protein oxidation 
 
Pure bovine serum albumin (BSA) solution and human plasma were incubated in the 
presence and absence of 10 mM 2,2’-azobis(amidinopropane) dihydrochloride 
(AAPH) in an incubator (Bioline, Edwards Instrument Company, Australia) at a 
temperature of 37˚C in an orbital motion at a speed of 80 rpm.  The constant motion 
ensured oxygenation of the solutions.  At set times points, samples were removed and 
analysed for the concentration of PrOOHs, cholesterol dienes or α-tocopherol 
concentration by the methods described in sections 2.2.3, and 2.2.8 respectively. 
 
2.2.3 Protein hydroperoxide determination by the FOX assay 
 
A) 25 mM Sulfuric acid FOX assay 
PrOOHs on BSA were measured by the sulphuric acid FOX assay, as modified by 
Gay et al. (1999a and b).  As it lacks a delipidation procedure, this assay is only able 
to measure PrOOH in lipid-free systems like pure BSA.  1 ml samples were removed 
from BSA solutions in triplicate into 1.8 ml clear centrifuge tubes (Axygen) at 
selected time points.  140 μl of 72% trichloroacetic acid (TCA) was added and 
vortexed to mix before being left on ice for five minutes.  This is to ensure that there 
is complete precipitation of the proteins.  The eppendorf tubes were subsequently 
centrifuged at 4˚C, 10, 000 rpm for seven minutes and the supernatant decanted off.  1 
ml of 5% TCA was added, the pellet resuspended using sealed Pasteur pipettes (Chase 
Scientific Glass, Inc) and centrifuged again.  This washing step was repeated.  After 
the second wash the supernatant was removed and the pellet resuspended in 900 μl of 
25 mM H2SO4 using the sealed glass rod before 50 μl of 5 mM xylenol orange was 
added and mixed by vortexing.  50 μl of 5 mM ferrous ammonium sulfate was added, 
vortexed and incubated at room temperature in the dark for 30 minutes.  The samples 
were transferred to cuvettes (Sarstedt) and the absorbance read against a water blank 
at 560 nm on a UV-visible spectrophotometer (model UV-1601PC, Shimadzu) using 
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the UV Probe software (Shimadzu).  The concentration was calculated using the 
extinction coefficient of 35, 500 M-1cm-1 for BSA hydroperoxides in H2SO4. 
 
B) Acetic acid FOX assay 
The acetic acid FOX assay was modified by Pearson, (2002) and can detect PrOOHs 
produced in AAPH-treated lipoproteins and AAPH-treated plasma.  200 μl of sample 
was removed from plasma solutions in triplicate into 1.8 ml clear centrifuge tubes 
(Axygen) at selected time points and diluted 1/5 with nanopure water.  140 μl of 72% 
TCA was added to sample, vortexed to mix and then left on ice for five minutes.  The 
samples were centrifuged at 10, 000 rpm for seven minutes at 4˚C to pellet the protein 
and then the supernatant was decanted.  The pellets were resuspended in 1 ml of 1:1 
methanol/chloroform solution using sealed Pasteur pipettes, before being centrifuged 
again.  The supernatant was decanted once more and the pellets dried by placing the 
1.8 ml centrifuge tubes upside down for five minutes.  900 μl of 50% aqueous acetic 
acid was then added to the dried pellets and also to the blank eppendorf tubes.  The 
pellets were resuspended and vortexed briefly to mix.  50 μl of 5 mM xylenol orange 
was added to all the 1.8 ml centrifuge tubes and mixed to distribute evenly.  50 μl of 5 
mM ferrous ammonium sulfate was then added and also vortexed to mix.  The 
samples were incubated for 30 minutes in the dark at room temperature before reading 
the absorbance at 560 nm against the blank.  Using the coefficient 32, 500 M-1cm-1 
and the dilution factor of 1/5, the concentration of PrOOH in plasma was calculated. 
 
2.2.4 Plasma dialysis for protein oxidation 
 
The dialysis bags were made from 14 kDal dialysis tubing (14.3 mm in diameter, 
supplied by Medicell International, Ltd) having previously been treated by boiling in 
5% (w/v) NaHCO3 and 1 mM EDTA before extensive washing and further boiling in 
nanopure water.  The tubing was stored in 50% ethanol solution and was thoroughly 
washed with distilled water when required for dialysis.   
 
PBS for dialysis was prepared the previous day and left stirring for 24 hours.  The 
plasma was placed inside the prepared dialysis bag and the top layered with argon gas.  
Plasma was dialysed against four 1 litre changes of chelex-treated, nitrogen-degassed 
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PBS over a 24 hour period in a darkened room with the temperature maintained at 
4˚C.     
 
2.2.5 HPLC analysis of ascorbic acid and uric acid  
 
Detection of ascorbic acid and uric acid was achieved by ion-pair liquid 
chromatography on a Shimadzu (New Zealand, Ltd) SIL-10A automated high-
performance liquid chromatography (HPLC) machine with electrochemical detection 
at +60 volts.  This protocol was adapted from Frei et al. (1988).  The mobile phase 
was filtered through a 0.22 μM filter, sonicated for 20 minutes and pumped though 
the column overnight for a minimum of 16 hours at 1 ml/min.  The column used for 
the detection was a reverse phase phenosphere 5 μm C18, 250 x 4.60 mm with a guard 
column.  The column was kept in a Shimadzu CTO-10A column oven at a 
temperature of 30˚C while being used.  Uric acid and ascorbic acid standards were 
freshly prepared at the beginning of the analysis, and 100 μl of the standard and 
samples were placed into autosampler vials with 10 μl injected into the HPLC.  
Ascorbic acid and uric acid eluted as single peaks, with uric acid at five minutes and 
ascorbic acid at seven minutes.  The peak areas were calculated using Shimadzu Class 
VP (Version 6.12 SP4) software. 
 
2.2.6 Determination of uricase concentration  
 
Different concentrations of uricase were prepared and added to ascorbic acid and uric 
acid standards.  The solutions were incubated for 30 minutes to determine the 
concentration that blocked uric acid.  As 1 mg/ml uricase was subsequently found to 
block uric acid formation, this concentration was incubated with plasma at 37˚C for 
30 minutes.  200 μl of sample was then added to 800 μl of 90% 
methanol/water/EDTA and left on ice for five minutes in the dark to precipitate 
protein.  Samples were centrifuged at 10, 000 rpm for ten minutes at 5˚C before being 
analysed for uric acid content by HPLC. 
 
2.2.7 The role of amino acids in protein oxidation 
 
Plasma was dialysed, to remove free amino acid and specified amino acids were then 
added back to the dialysed plasma at 250 or 500 mM.  The control was also dialysed 
but with PBS rather than amino acids to ensure the plasma in all treatments was of a 
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consistent dilution.  The role of amino acids in plasma protein oxidation was 
examined by exposing each treatment to AAPH before measuring PrOOHs via the 
acetic acid FOX assay.  
 
2.2.8 Determination of cholesterol diene and α-tocopherol 
concentration by HPLC 
 
Cholesterol diene formation in LDL was carried out by modifying the originally 
developed by Kritharides et al. (1993).  500 μl of plasma sample was removed from 
plasma solutions in triplicate into 15 ml black-top glass tubes.  20 μl of 20 mg/ml 
EDTA, 20 μl of 100 mg/ml BHT and 1 ml of cold methanol was added to the test 
tubes and vortexed for ten seconds.  5 ml of hexane was added and vortexed for 30 
seconds before the tubes were sealed with parafilm and stored in the -80˚C freezer 
until analysis.  On analysis, the samples were removed from the freezer and thawed.  
They were vortexed for 30 seconds and then centrifuged for three minutes at 5˚C, 1, 
000rpm.  The top 4 ml of hexane was transferred into a tapered glass test tube and 
dried down under nitrogen in an oxygen-free hot water bath.  The residue was 
reconstituted in 100 μl of mobile phase and placed in an autosampler vial.  A 20 μl 
injection was passed through an Econosphere C18 5μm column (Alltech Associates 
Inc., U.S.A), maintained at 35˚C inside a Shimadzu CTO-10A column oven.  The 
mobile phase, consisting of acetonitrile/isopropanol/water in a ration of 44:54:2, was 
pumped at a flow rate of 1 ml/min.  Cholesterol dienes were detected by UV 
absorbance using a SPD-10A ultraviolet detector at a wavelength of 234 nm.  This 
was joined in series to a fluorescence detector, with an excitation of 292 nm and an 
emission of 335 nm, to also enable for α-tocopherol detection.  A colesteryl linoleate 
standard was prepared prior to analysis and stored in the -80˚C freezer, while a 3 μM 
α-tocopherol standard was made up by diluting the 100 μM stock solution (stored in 
the -20˚C freezer) in cold methanol.  The peak areas were calculated using Shimadzu 
Class VP (Version 6.12 SP4) software and the concentration of dienes and α-
tocopherol was determined quantitatively by comparison with the known standard of 
the dienes or α-tocopherol.   
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2.2.9 Irradiation of BSA 
 
5 ml of the 1 mg/ml solution of BSA in PBS was transferred to a 20 ml scintillation 
vial and placed in the X-ray source (Philips model PW2264-20 tungsten x-ray 
generator, 35kV, 30mA) directly below the aperature.  A small tube connected to an 
oxygen cylinder was placed inside the scintillation vial to allow constant bubbling of 
oxygen through the BSA over the radiation period.  The PB-DOPA content of the 
irradiated BSA was analysed by the ED-DOPA assay or HPLC fluorescence analysis 
for PB-DOPA after acid hydrolysis. 
 
2.2.10 Fricke Dosimeter Assay 
 
Under aerobic conditions, irradiation produces a constant flux of hydroxyl radicals 
((Halliwell and Gutteridge, 1990; Cudina and Josimovic, 1987).  The Fricke 
dosimeter assay is used to determine the rate of this flux and was performed to 
calibrate the X-ray source.  10 ml of 1 mM ferrous ammonium sulfate, 0.6 mg of 
sodium chloride and 0.22 ml of concentrated sulfuric acid were mixed to form the 
Fricke solution.  The Fricke solution was exposed to irradiation for ten minutes and 
the absorbance was measured at 304 nm against a Fricke solution not exposed to X-
rays. 
Dose rate (in Gy/min) = 286 x absorbance / time of exposure 
                                G =  5.8 Gy/min. 
 
2.2.11 PB-DOPA production via Fenton reaction  
 
The analysis of PB-DOPA generated on BSA exposed to the Fenton reaction was 
modified from the method used by Gieseg et al. (1993).  BSA at a concentration of 1 
mg/ml, was made up using 10 mM chelexed sodium phosphate buffer.  15 ml 
centrifuge tubes consisting of 0, 40, 70, or 100 μM copper chloride were prepared 
containing BSA and 5 mM hydrogen peroxide.  The tubes were covered with tin foil 
to permit the continual circulation of oxygen while being gently mixed at 100 rpm for 
the duration of the 30 minute incubation at 37˚C.  25 μl of 5μg/ml catalase and 0.25 g 
of washed chelex-100 were then added to stop the reaction and remove free metal 
ions.  The tubes were rotated in a 4˚C room for two hours, and then centrifuged at 1, 
500 rpm for five minutes to pellet the chelex.  200 μl of supernatant was placed in 
Durham tubes and freeze dried in a Speed Vac in preparation for acid hydrolysis and 
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HPLC analysis.  500 μl of sample was placed in labelled eppendorfs for analysis by 
the ED-DOPA assay.  
 
2.2.12 ED – DOPA assay 
 
This assay was originally developed by Sutherland et al. (2003) and modified by 
Parkes, (2005).  500 μl of irradiated BSA was placed in triplicate in labelled 1.8 ml 
clear centrifuge tubes and 500 μl PBS, 50μl ethylenediamine dihydrochloride and 70 
μl ethylenediamine added.  DOPA standards of 0, 5, 10, 25 and 50 μM were made up 
and also mixed with 500 μl PBS, 50μl ethylenediamine dihydrochloride and 70 μl 
ethylenediamine.  All samples and standards were vortexed and incubated in a 50˚C 
incubator.  After a one hour incubation, the fluorescence was measured against a 
water blank using a fluorescence spectrophotometer (Cary Eclipse) at an excitation of 
430 nm and an emission of 545 nm.  The fluorescence (y) was recorded by operating 
the Advanced Reads software (Cary Eclipse), with the concentration of PB-DOPA (x) 
calculated using the slope (m) and y-intercept (c) from the standard curve of the 
standards and the equation x=(y-c)/m.   
 
2.2.13 HPLC analysis of PB-DOPA 
 
A) Acid hydrolysis 
Acid hydrolysis and HPLC analysis of the hydrolysates is based on a method 
developed by Gieseg et al. (1993), with further adaptation by Parkes, (2005).  200 μl 
of sample was placed in triplicate in labelled Durham tubes (7.5 x 50 mm, Biolab) and 
dried in the speed vacuum.  Once dry, the Durham tubes were placed in Pico-Tag 
reaction vials (Millipore, USA), with 1 ml 6M HCl with 1% w/v phenol and 50 μl 
mercaptoacetic acid in the bottom of the reaction vials.  The vials were flushed with 
argon then evacuated by a vacuum pump before closing the valve and incubating at 
110˚C for 16 hours.  Subsequently, the vials were removed and cooled before 
opening.  200 μl of 0.1% TFA was added to each Durham tube, vortexed to dissolve 
hydrolysate residue and then centrifuged for 15 minutes at 10 000 rpm to pellet 
undissolved residues.  The supernatant was transferred into labelled 1.8 ml clear 
centrifuge tubes and centrifuged.  100 μl of the supernatant was placed in an 
autosampler vial with 10 μl injected into the HPLC for analysis.   
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B) HPLC analysis of acid hydrolysates 
10 μl samples were injected and run through an Aqua C18 125A 250 x 4.6 mm HPLC 
column (Phenomenex, New Zealand) that was maintained at 35˚C in the column oven.  
The combination of 0.1% TFA as mobile phase A and acetonitrile as mobile phase B 
was used and run at 1 ml/min.  Mobile phase B was run at 1% for the first ten 
minutes, and changed to 5% for the next four minutes, 10% for two minutes, 5 % for 
seven minutes and 1% for the last seven minutes.  PB-DOPA was detected by 
fluorescence on a Shimadzu fluorescence detector with an excitation of 280 nm and 
emission of 320 nm.  The peak area was determined by Shimadzu Class VP (Version 
6.12 SP4) software with the PB-DOPA concentration calculated by comparison of the 
peak area with the 1 μM DOPA standard peak area. 
 
2.2.14 ED-DOPA assay accuracy 
 
10 ml of 1 mg/ml BSA, in 10 mM non-chelexed sodium phosphate buffer was placed 
in a scintillation vial and exposed to radiation for 60 minutes. 
4.42 ml of irradiated and unirradiated BSA was transferred to falcon tubes.  Half the 
samples in each treatment were mixed with 577 μl of 1 mM copper sulfate while the 
other half were mixed with 577 μl PBS.  All the tubes were mixed and incubated at 
37˚C, 110 rpm for two hours.  25 μl of catalase and 0.25 g chelex were added to the 
tubes containing copper sulfate to stop the reaction and remove free metal ions.  The 
tubes were mixed and placed on the rotator in the dark, 4˚C room for two hours before 
being centrifuged for five minutes at 1, 500 rpm to pellet the chelex.  200 μl of each 
sample was placed in Durham tubes to be dried down in the Speed Vac for acid 
hydrolysis and HPLC DOPA analysis.  A further 500 μl of each sample was placed in 
labelled centrifuge tubes for ED assay analysis.   
 
2.3 Statistical analysis 
 
Results shown were obtained from single experiments representing a minimum of 
three repetitions of the same experiment under identical conditions.  Each data point 
represents a duplicate or triplicate in each treatment and is expressed in the form of 
mean value plus standard error of the mean.  The standard error is represented on the 
graphs by symmetrical error bars.  The statistical analysis was performed using 
PRISM software (Version 4, Graphpad Software, Inc).  Comparison treatments within 
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experiments were analysed using one-way analysis of variance (ANOVA) followed 
by Tukey’s multiple comparisons test.  Statistical significance is shown using the 
following notation * p ≤ 0.05 (significant), ** p ≤ 0.01 (very significant), *** p ≤ 
0.001 (highly significant).  These notations represent the significance of the data from 
its zero time value. 
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RESULTS 
 
3.1 Protein oxidation induced by AAPH 
 
3.1.1 PrOOH formation on BSA 
 
AAPH is a water-soluble azo radical initiator that decomposes at a temperature 
dependent rate, generating a constant flux of peroxyl radicals (Niki, 1990).  The use of 
AAPH, therefore, enables both lipid and protein oxidation to be studied in a defined 
system. 
 
The kinetics of PrOOH formation on pure proteins was investigated by incubating 2 
mg/ml of pure BSA with and without 10 mM AAPH at 37˚C over a five hour period 
(Figure 3.1.1).  Under such conditions, a linear increase in PrOOH formation was 
observed over the five hours, whereas BSA incubated with no AAPH displayed very 
little PrOOH formation over the same period.  The 10 mM AAPH-mediated 
production of PrOOHs occurred at a rate of 1.7 μM during the first hour of incubation, 
slowing to a rate of 0.8 μM over the next 4 hours. 
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Figure 3.1.1 Peroxyl radical-mediated PrOOH formation on BSA 
BSA, at a concentration of 2 mg/ml, was incubated at 37˚C in the presence and absence of 10 
mM AAPH.  Incubation was over a five hour period, with samples removed for analysis at 
selected time intervals.  Hydroperoxides were measured by the sulfuric acid FOX assay with 
the PrOOH concentration adjusted against blank controls and time zero PrOOH values.  Each 
data point represents the mean ± SEM of triplicate samples. 
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3.1.2 PrOOH formation in human plasma 
 
Proteins are thought to be a major target molecule of radical attack in the oxidation 
process (Gebicki, 1997).  The kinetics of PrOOH formation in peroxyl radical 
oxidized plasma had previously been investigated by Ling, (2004) and Yang, (2005).  
Both identified a lag phase of six-eight hours when plasma was incubated with 10 
mM AAPH.  This experiment was reproduced in the current study to confirm the 
existence of a lag phase, with human blood plasma being incubated in the presence 
and absence of 10 mM AAPH at 37˚C over a 24 hour period (Figure 3.1.2).  Samples 
were removed every two hours and PrOOH formation measured using the acetic acid 
FOX assay, which is designed to determine PrOOH formation in lipid containing 
systems such as plasma.  Plasma lacking 10 mM AAPH showed very little PrOOH 
formation over the 24 hour period, indicating no auto-oxidation of proteins, while 
plasma incubated with 10mM AAPH produced a six hour lag phase where little or no 
PrOOH formation occurred.  The six hour lag phase was followed by an increase in 
PrOOH formation, at a rate of 3.7 μM, and ultimately by a decrease/plateau in 
production between the 12 and 24 hour time points that was attributed to the 
degradation of PrOOHs.  The prominence of this plateau varied between experiments 
due to the use of different batches of plasma.  Likewise, the precise rate of formation 
also showed some variation.  The small increase after two hours observed in Figure 
3.1.2, was not significant and may have been an experimental variant as it was not 
observed in all experiments.  The lag phase was, however consistently detected in all 
experiments.  Thus having confirmed its existence the main objective of the current 
study could begin expanding the work of Ling, (2004) and Yang, (2005), by trying to 
define the source of the six hour lag phase during AAPH-induced plasma. 
 
The source of the lag phase was initially investigated by dialysing the plasma to 
remove small molecular weight molecules (Figure 3.1.3).  In agreement with Yang, 
(2005), dialysed plasma was not associated with a lag phase when incubated with 10 
mM AAPH.  PrOOH formation began immediately in the absence of the plasma’s 
small molecular weight components.  Such components include ascorbic acid, uric 
acid and free amino acids. 
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Figure 3.1.2 Peroxyl radical-mediated PrOOH formation in plasma 
Plasma was incubated at 37˚C in the presence and absence of 10 mM AAPH.  
Incubation was over a 24 hour period, with samples removed for analysis at selected 
time intervals.  Protein hydroperoxides were measured by the acetic acid FOX assay 
and adjusted against blank controls and the corresponding time zero PrOOH values.  
Each data point represents the mean ± SEM of triplicate samples. 
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Figure 3.1.3 Peroxyl radical-mediated PrOOH formation in dialysed plasma 
Dialysed plasma was incubated at 37˚C with 10 mM AAPH over a 24 hour period.  Samples 
were removed at selected time points for PrOOH analysis by the acetic acid FOX assay and 
adjusted against blank controls and the corresponding time zero PrOOH values.  Each data 
point represents the mean ± SEM of triplicate samples. 
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3.2 Concentration of ascorbic acid and uric acid in plasma 
 
To investigate whether ascorbic and/or uric acid were responsible for the lag phase 
observed when plasma is incubated with 10 mM AAPH (Figure 3.1.2), both 
antioxidants were first analysed by HPLC in undialysed plasma to monitor their 
concentration during a 24 hour incubation.  It was observed that ascorbic acid became 
completely depleted in plasma within two hours of exposure to AAPH, suggesting it 
may play a role in protecting for the first two hours while the ascorbic acid oxidation 
product, DHA protects during the rest of the lag phase, however cannot be solely 
responsible for the six hour lag phase (Figure 3.2.1).  Uric acid decreased in 
concentration over time but approximately 15 μM and 7 μM remained even after six 
hours and 24 hours respectively.  This suggests that, although uric acid may provide 
some protection, it is not responsible for the inhibition of PrOOH formation during 
the lag phase.   
 
 
0 4 8 12 16 20 24 28
0
5
10
15
20 Urate
Ascorbate
0
20
40
60
80
100
120
140
Time (Hour)
A
sc
or
bi
c 
ac
id
 c
on
ce
nt
ra
tio
n 
(µ
M
) U
ric acid
concentration ( μM
)
 
Figure 3.2.1 AAPH decreases the concentration of ascorbic acid and uric acid in 
plasma 
Plasma was incubated at 37˚C in the presence of 10mM AAPH.  Incubation was over a 24 
hour period, with samples removed for analysis of uric acid and ascorbic acid via HPLC at 
selected time intervals.  Each data point represents the mean ± SE of triplicate samples. 
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3.3 Effect of plasma antioxidants on the PrOOH lag phase of 
AAPH-mediated human plasma oxidation 
 
3.3.1 Effect of free amino acids on PrOOH formation in AAPH-
mediated oxidation of dialysed plasma 
 
Free amino acids in the plasma are thought to act as sacrificial antioxidants, protecting 
proteins from free radical attack.  Literature searches produced a list of free amino 
acid concentrations found in human plasma (Wu et al., 1998; Chuang et al., 2005; 
Borden et al., 1952; Glew et al., 2004; Muscaritoli et al., 1999; Tcherkas and 
Denisenka, 2001; Filho et al., 1997; Gregory et al., 1986; Lepage et al., 1997).  The 
five amino acids with the highest concentrations were identified as valine, alanine, 
glutamine, lysine, and glycine. The effect of these five free amino acids on plasma 
protein oxidation was then investigated by supplementing dialysed plasma with 250 
mM of each of the amino acids.  This supplemented dialysed plasma was incubated 
with 10 mM AAPH at 37˚C and samples were removed for PrOOH analysis using the 
acetic acid FOX assay, at selected time points over a 24 hour period (Figure 3.3.1A).   
 
Dialysed plasma, supplemented with free amino acids, showed immediate production 
of AAPH-induced PrOOHs with a rapid increase in formation after two hours.  This 
was identical to the trend observed with dialysed but supplemented plasma, which 
was also exposed to 10 mM AAPH.  At ten and twelve hours there is a decrease in 
PrOOH formation.  There is no significant difference between the dialysed plasma 
and supplemented dialysed plasma at these time points indicating this is an 
experimental variant.  There is no sign of the six hour lag phase, indicating that under 
these conditions free amino acids do not play a role in the protection of the plasma 
proteins by acting as  sacrificial antioxidants for the first six hours of peroxyl radical 
attack.   
 
To determine whether a higher concentration of free amino acids could inhibit AAPH-
induced protein oxidation in plasma, the experiment was repeated but this time 
dialysed plasma was supplemented with 500 mM of each of the five amino acids 
(Figure 3.3.1B).  However, the rate of PrOOH formation in dialysed plasma remained 
unchanged from the rate in dialysed plasma supplemented with this higher 
concentration of amino acids.   
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Some amino acids are more susceptible to peroxide formation and may therefore be 
more efficient as sacrificial antioxidants than their less susceptible counterparts.  To 
investigate whether the more reactive free amino acids in plasma were contributing to 
the lag phase, a literature search was undertaken to identify the free amino acids in 
order of reactivity (Gebicki and Gebicki, 1993).  Tyrosine, proline, leucine, 
isoleucine, arginine, and histidine were the six amino acids with the highest reactivity, 
and were subsequently added to dialysed plasma at a concentration of 500 mM each.  
The supplemented plasma was incubated with 10 mM AAPH at 37˚C for a 24 hour 
period, with samples analysed via the acetic acid FOX assay at selected time points 
(Figure 3.3.1C).  This result again showed no difference in the rate of PrOOH 
formation between dialysed plasma and supplemented plasma.  This indicates that 
free amino acids do not act as sacrificial antioxidants and do not contribute to the six 
hour lag phase in peroxyl radical-induced PrOOH formation in plasma. 
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Figure 3.3.1 Peroxyl radical-mediated PrOOH formation in plasma incubated 
with and without free amino acids 
Plasma was incubated at 37˚C in the presence of 10 mM AAPH with and without free amino 
acids.  A) The free amino acids valine, alanine, glutamine, lysine and glycine were added to 
dialysed plasma at a concentration of 250 mM each.  B) The free amino acids valine, alanine, 
glutamine, lysine and glycine were added to dialysed plasma at a concentration of 500 mM 
each.  C) The free amino acids tyrosine, proline, leucine, isoleucine, arginine and histidine 
were added to dialysed plasma at a concentration of 500 mM each.  Incubation was over a 24 
hour period, with samples removed for analysis at selected time intervals.  Protein 
hydroperoxides were measured by the acetic acid FOX assay and adjusted against blank 
controls and the corresponding time zero PrOOH values.  Each data point represents the mean 
± SEM of triplicate samples. 
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3.3.2 Effect of ascorbic acid and uric acid on AAPH-mediated 
PrOOH formation in dialysed plasma 
 
Although free amino acids could not account for the lag phase during the AAPH-
mediated oxidation of plasma proteins, other small molecular weight molecules 
remained as viable candidates.  Yang, (2005) had previously added the antioxidants 
glutathione, bilirubin, ascorbic acid and uric acid to dialysed plasma, both separately 
and together, to observe their effect on the lag phase.  Glutathione and bilirubin did 
not restore the lag phase but ascorbic acid supplementation created a two hour lag 
phase, while uric acid supplementation was associated with a four hour lag phase.  
HPLC analysis shows ascorbic acid has disappeared from plasma within 30–60 
minutes, and so, is unlikely to be the sole instigator of the lag phase (Figure 3.2.1).  
From these results, it was suggested ascorbic acid and uric acid together might be 
producing the lag phase.  
 
In the current study, ascorbic acid and uric acid were both added at a physiological 
concentration of 50 μM and 300 μM respectively, to the same dialysed plasma and 
then incubated for one hour to allow equilibration.  The one hour equilibration period 
was required because without it, the uric acid and ascorbic acid did not appear to be 
present in the plasma.  This was shown by adding uric acid and ascorbic acid to 
dialysed plasma and then measuring the antioxidants via HPLC prior to the one hour 
incubation.  Only low levels of uric acid were detectable under such conditions (data 
not shown).  This solution was then incubated with 10 mM AAPH at 37˚C for a 24 
hour period, with samples removed at selected time points for PrOOH analysis using 
the acetic acid FOX assay.  Results show that when uric acid and ascorbic acid are 
added to dialysed plasma, the six hour lag phase is restored (Figure 3.3.2).  The result 
is identical during the first twelve hours to that observed in the undialysed plasma, but 
the dialysed plasma supplemented with uric acid and ascorbic acid subsequently keeps 
increasing while the undialysed plasma plateaus.  
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Figure 3.3.2 Peroxyl radical-mediated PrOOH formation in dialysed plasma 
supplemented with uric acid and ascorbic acid  
Dialysed plasma supplemented with ascorbic acid and uric acid was incubated with 10 mM 
AAPH at 37˚C.  Incubation was over a 24 hour period, with samples removed for analysis at 
two hour time intervals.   Protein hydroperoxides were measured by the acetic acid FOX 
assay and adjusted against blank controls and the corresponding time zero PrOOH values.  
Each data point represents the mean ± SEM of triplicate samples.  Significance values are 
shown between treatments. 
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3.3.3 Effect of uricase on AAPH-mediated PrOOH formation in 
plasma oxidation 
 
Uric acid is a well-known, major water-soluble antioxidant found in human plasma.  
As Yang, (2005) and Figure 3.3.2 illustrate, uric acid also appears to contribute to the 
protection of plasma proteins from oxidative attack.  To more fully confirm this 
antioxidants involvement in the PrOOH lag phase, the uric acid in undialysed plasma 
needed to be enzymatically removed and the loss of the lag phase subsequently noted.  
Uricase breaks down uric acid to produce allantoin and hydrogen peroxide and as a 
result, is a useful tool for blocking uric acid activity without removing or disrupting 
other molecules.   
 
To distinguish whether uric acid was the source of the lag phase by removing it from 
the plasma, plasma was incubated at 37˚C with 1 mg/ml of uricase for 30 minutes, 
before adding 10 mM AAPH and incubating at 37˚C for a further 24 hour period. 
Samples were removed at selected time points and analysed for PrOOHs by the acetic 
acid FOX assay.  Plasma incubated with 1 mg/ml uricase and no AAPH showed very 
little PrOOH formation, demonstrating that uricase was not causing autoxidation of 
the plasma (Figure 3.3.3).  Unexpectedly, AAPH-induced PrOOH formation in 
plasma exposed to 1 mg/ml uricase was associated with a six hour lag phase and this 
was not significantly different from the lag phase for control uricase-free plasma.  
After this six hour lag phase, the increase of PrOOHs in the uricase treatment was 
almost double the level of protein peroxidation in uricase-free plasma.  The rapid 
increase continued up to 24 hours and was followed by a decrease between 24 and 48 
hours.  Uricase-free plasma incubated with 10 mM AAPH showed the characteristic 
six hour lag phase and then the formation of PrOOHs between six and 24 hours, with 
a plateau occurring between 24 and 48 hours.  
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Figure 3.3.3 Peroxyl radical-mediated PrOOH formation in plasma incubated 
with and without 1 mg/mL uricase 
Plasma was incubated at 37˚C in the presence and absence of 10 mM AAPH and 1 mg/mL 
uricase.  Incubation was over a 24 hour period, with samples removed for analysis at selected 
time intervals.  Protein hydroperoxides were measured by the acetic acid FOX assay and 
adjusted against blank controls containing and the corresponding time zero PrOOH values.  
Each data point represents the mean ± SEM of triplicate samples. 
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3.3.4 Effect of excess urate on AAPH-mediated PrOOH formation in 
undialysed plasma 
 
If uric acid is responsible for the lag in AAPH-induced PrOOH formation, excess uric 
acid should extend this lag phase beyond six hours.  To further explore the effect of 
uric acid on the six hour lag phase, excess uric acid was therefore added to 
undialysed. 600 μL of uric acid, which is double the normal physiological 
concentration found in plasma, was added to undialysed plasma and incubated for 60 
minutes to allow the uric acid to equilibrate.  The plasma was then incubated with 10 
mM AAPH over a 24 hour period, with samples removed at selected time points for 
analysis of PrOOH formation using the acetic acid FOX assay.  Results show that 
excess uric acid extended the lag phase from six hours to twelve hours, with very little 
PrOOH formation occurring during that time.  The slight increase in PrOOH 
formation at six hours was not significant and had disappeared by eight hours, 
suggesting it was an experimental variant.  From this result, we are able to conclude 
that uric acid contributes to the lag phase in PrOOH formation that is observed when 
plasma is oxidized by AAPH. 
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Figure 3.3.4 Peroxyl radical-mediated PrOOH formation in undialysed plasma 
incubated with excess uric acid 
Excess uric acid was added to undialysed plasma and incubated with 10 mM AAPH at 37˚C.  
Incubation was over a 24 hour period, with samples removed for analysis at selected time 
intervals.   Protein hydroperoxides were measured by the acetic acid FOX assay and adjusted 
against blank controls and the corresponding time zero PrOOH values.  Each data point 
represents the mean ± SEM of triplicate samples. 
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3.4 Effect of AAPH-mediated lipid oxidation in human 
plasma 
 
Through continuous monitoring of lipid oxidation products, Esterbauer et al. (1989) 
was able to determine that diene formation consists of three phases in LDL.  The first 
is a lag phase where very few or no dienes are produced, followed by a propagation 
phase where dienes rapidly increase, and finally a decomposition phase where dienes 
decrease.  Continuous measurement of diene formation via spectrophotometer is a 
good marker of lipid oxidation, as is the more specific measurement of cholesterol 
dienes via HPLC.  The HPLC measurement was therefore used to investigate the 
phases of lipid oxidation, and to observe if there is a link between protein oxidation 
and lipid oxidation, plasma was incubated with 10 mM AAPH over a 24 hour period.  
Samples were removed at selected time points for the measurement of cholesterol 
dienes formation by HPLC analysis at an absorbance of 234 nm.  The diene 
concentration was determined by the comparison with a standard of known 
concentration.   
 
The results show a two hour lag phase where no cholesterol diene formation occurs, 
followed by a rapid increase in cholesterol diene formation over the rest of the 24 
hours (Figure 3.4.1).  Although the concentration continued to increase over the time 
course, there was a slowing of formation between 12 and 24 hours.  Plasma incubated 
without AAPH showed no cholesterol diene formation confirming that no auto-
oxidation was occurring in the plasma.  AAPH-induced lipid oxidation commencing 
in the plasma after a two hour lag phase suggests that a difference exists between lipid 
and protein oxidation, with the latter commencing only after a six hour lag phase 
(Figure 3.4.2).   
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Figure 3.4.1 Peroxyl radical-mediated cholesterol diene formation in plasma 
Human plasma was incubated in the presence and absence of 10 mM AAPH at 37˚C.  
Incubation was over a 24 hour, period with samples removed for analysis at selected time 
intervals.  Cholesterol dienes were measured by HPLC analysis at an absorbance of 234 nm.  
Each data point represents the mean ± SEM of triplicate samples. 
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3.4.2 Peroxyl radical-mediated PrOOH formation and cholesterol diene 
formation in human plasma 
Human plasma was incubated at 37˚C in the presence of 10 mM AAPH for a 24 hour period.  
Samples were removed at selected time intervals for analysis of PrOOH formation by the 
acetic acid FOX assay and cholesterol diene formation by HPLC analysis at an absorbance of 
234 nm.  Each data point represents the mean ± SEM of triplicate samples. 
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3.4.2 Cholesterol diene formation in dialysed plasma exposed 
to peroxyl radicals 
 
Dialysing the plasma before incubation with 10 mM AAPH caused a loss of the six 
hour PrOOH lag phase (Figure 3.1.3), but it was not known whether a similar result 
would be observed for lipid oxidation.  Examining the effect of dialysis on cholesterol 
diene formation may indicate whether the lag phases for the protein and lipid 
oxidation systems are connected.  Human plasma was therefore dialysed in PBS and 
then incubated with 10 mM AAPH at 37˚C over a 24 hour time period.  Samples were 
removed at selected time points for analysis of cholesterol diene concentration via 
HPLC analysis at an absorbance of 234 nm.   
 
The two hour lag phase, where no cholesterol diene formation occurred, disappeared 
when the dialysed plasma was incubated with 10 mM AAPH (Figure 3.4.3).  This 
agrees with the loss of the PrOOH lag phase (Figure 3.1.3).  Cholesterol dienes 
formed immediately, and the concentration continued to increase in a linear fashion 
over the 24 hour period.  The concentration of cholesterol dienes was also double the 
concentration usually observed in undialysed plasma incubated with 10 mM AAPH 
(Figure 3.4.1 compared to Figure 3.4.3).  This indicates that one of the small molecule 
antioxidants must be causing the two hour lag phase and also reducing the radical 
flux, giving a lowered cholesterol diene concentration.  Furthermore, dialyzable 
antioxidants appear to be the source of both the PrOOH and cholesterol diene lag 
phases.  The rate of cholesterol diene formation over the first six hours is 19 μM/hour 
and, after the depletion of α-tocopherol in dialysed plasma at eight hours, there is a 
reduction in the rate of formation to 10.24 μM/hour (Figure 3.5.2).  Perhaps the α-
tocopherol acts as a pro-oxidant while present, and once depleted, the rate of 
oxidation can then reduce. 
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Figure 3.4.3 Peroxyl radical-mediated cholesterol diene formation in dialysed 
plasma 
Human plasma was dialysed and incubated in the presence of 10 mM AAPH at 37˚C.  
Incubation was over a 24 hour period, with samples removed for analysis at selected time 
intervals.  Cholesterol dienes were measured by HPLC analysis at an absorbance of 234 nm.  
Each data point represents the mean ± SEM of triplicate samples. 
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3.4.3 Effect of ascorbic acid on AAPH-mediated cholesterol 
diene formation in dialysed plasma 
 
HPLC analysis of ascorbic acid established that this antioxidant was completely 
depleted from plasma after a 30 minute incubation at 37˚C.  The removal of the two 
hour lag in of cholesterol diene formation by dialysis coincides approximately with 
the depletion of ascorbic acid in plasma.  This suggests that ascorbic acid may be 
causing the two hour lag phase and reducing the radical flux.  To investigate this 
theory, ascorbic acid was added to dialysed plasma and incubated at 37˚C for one 
hour to allow the ascorbic acid to equilibrate with the dialysed plasma.  The dialysed 
plasma was then incubated with 10 mM AAPH at 37˚C over a 24 hour period.  
Samples were removed at selected time points, with cholesterol diene concentration 
measured by HPLC analysis at an absorbance of 234 nm.   
 
Dialysed plasma, supplemented with ascorbic acid, showed very little cholesterol 
diene formation in the first two hours (Figure 3.4.4).  This restoration of the lag phase 
indicates that ascorbic acid is responsible for protecting the plasma lipids from radical 
attack during the first two hours.  Although the two hour lag phase reproduces the 
result in undialysed plasma, the AAPH-induced formation of cholesterol dienes after 
the lag phase is more similar to the undialysed but unsupplemented plasma.  Due to 
there being no change in the rate of the propagation phase, ascorbic acid must not be 
reducing the radical flux post-lag phase.  Ascorbic acid has been found to act as a co-
antioxidant regenerating α-tocopherol from the α-tocopherol radical and therefore 
inhibiting tocopherol-mediated peroxidation (TMP) (Upston et al., 1999).  Perhaps 
ascorbic acid is fulfilling a similar function in this study, regenerating α-tocopherol 
and thereby inhibiting lipid oxidation while the ascorbic acid is present.   
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Figure 3.4.4 Peroxyl radical-mediated cholesterol diene formation in dialysed 
plasma supplemented with ascorbic acid 
Dialysed plasma was supplemented with ascorbic acid and incubated with 10 mM AAPH at 
37˚C.  Incubation was over a 24 hour period, with samples removed for analysis at selected 
time intervals.  Cholesterol dienes were measured by HPLC analysis at an absorbance of 234 
nm.  Each data point represents the mean ± SEM of triplicate samples. 
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3.4.4 Effect of uric acid on AAPH-mediated cholesterol diene 
formation in dialysed plasma 
 
Figure 3.4.4 shows a return of the lag phase when ascorbic acid is present in plasma 
but does not reduce the rate of cholesterol diene formation post-lag phase.  This 
suggests another small molecular weight antioxidant is responsible for the reduction 
in the rate of cholesterol diene formation once ascorbic acid is depleted and lipid 
peroxidation begins.  Plasma protein oxidation experiments found that ascorbic acid 
and uric acid were responsible for the six hour PrOOH lag phase, with uric acid 
providing the antioxidant activity after the depletion of ascorbic acid (Figure 3.3.2).  
This suggests uric acid may also be responsible for the reduction in the rate of 
cholesterol diene formation in plasma post-lag phase.  This involvement of uric acid 
in the reduction of the radical flux was therefore investigated by adding uric acid to 
dialysed plasma and incubating at 37˚C for one hour to allow equilibration.  The 
supplemented dialysed plasma was then incubated with 10 mM AAPH at 37˚C over a 
24 hour period.  Samples were removed at selected time points, with cholesterol diene 
concentration measured by HPLC analysis at an absorbance of 234 nm. 
 
There was a reduction in the rate of cholesterol diene formation during the first two 
hours compared to dialysed but unsupplemented plasma but, unlike ascorbic acid 
supplementation, the lag phase was not restored (Figure 3.4.5).  The reduced rate of 
cholesterol diene formation continued over the 24 hour period and was more similar 
to the trend in undialysed plasma than dialysed but unsupplemented plasma, 
especially between two and twelve hours.  During this time dialysed but 
unsupplemented plasma produced 12. 2 μM cholesterol dienes per hour, whereas 
dialysed plasma supplemented with uric acid  and undialysed plasma produced 11 μM 
and 6.64 μM cholesterol dienes per hour respectively.  Between 12 to 24 hours the 
cholesterol diene concentration in dialysed, supplemented plasma remained 
significantly below the concentration in the dialysed unsupplemented plasma.  It did, 
however, increase significantly above the level of cholesterol dienes in undialysed 
plasma.  This suggests that uric acid is not responsible for the two hour lag phase but 
is responsible for reducing the radical flux by scavenging the radicals after the 
depletion of ascorbic acid.   
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Figure 3.4.5 Peroxyl radical-mediated cholesterol diene formation in dialysed 
plasma supplemented with uric acid 
Dialysed plasma was supplemented with uric acid and incubated with 10 mM AAPH at 37˚C.  
Incubation was over a 24 hour period, with samples removed for analysis at selected time 
intervals.  Cholesterol dienes were measured by HPLC analysis at an absorbance of 234 nm.  
Each data point represents the mean ± SEM of triplicate samples.  Significance values shown 
are between treatments. 
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3.4.5 Effect ascorbic acid and uric acid on AAPH-mediated 
cholesterol diene formation in dialysed plasma 
 
The previous two experiments (Figures 3.4.4 and 3.4.5) indicate that ascorbic acid is 
responsible for the two hour lag phase, when no cholesterol dienes are formed.  Uric 
acid was found to be responsible for the lowered rate of cholesterol diene formation 
post-lag.  It was possible that incubating dialysed plasma with both antioxidants 
simultaneously would restore all kinetics observed with undialysed plasma.  To 
investigate this theory, dialysed plasma was supplemented with both ascorbic acid and 
uric acid and equilibrated for one hour at 37˚C.  The supplemented plasma was then 
incubated with 10 mM AAPH over a 24 hour time period, with samples removed at 
selected time intervals for cholesterol diene formation by HPLC analysis at an 
absorbance of 234 nm.   
 
The two hour lag phase was largely restored, and a reduction in cholesterol diene 
formation was also observed, when dialysed plasma was supplemented with both 
ascorbic acid and uric acid (Figure 3.4.6).  The trend was very similar to that observed 
when undialysed plasma is incubated with AAPH.  However, as observed in Figure 
3.4.5, the cholesterol diene concentration in the dialysed supplemented plasma did 
become significantly elevated compared to the undialysed plasma treatment between 
12 and 24 hours.   
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Figure 3.4.6 Peroxyl radical-mediated cholesterol diene formation in dialysed 
plasma supplemented with uric acid and ascorbic acid 
Dialysed plasma was supplemented with uric and ascorbic acid and incubated with 10 mM 
AAPH at 37˚C.  Incubation was over a 24 hour period, with samples removed for analysis at 
selected time intervals.  Cholesterol dienes were measured by HPLC analysis at an 
absorbance of 234 nm.  Each data point represents the mean ± SEM of triplicate samples.  
The significance values shown are for between treatments. 
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3.5 α-Tocopherol (Vitamin E) concentration in plasma 
exposed to peroxyl radicals 
 
3.5.1 α-Tocopherol concentration in plasma 
 
α-Tocopherol is the main antioxidant in LDL, with an average of six molecules per 
lipoprotein particle (Esterbauer et al., 1989).  As such, it is also expected to be a 
significant antioxidant in plasma.   To investigate the activity of α-tocopherol in 
plasma undergoing oxidation, plasma was incubated with and without 10 mM AAPH 
at 37˚C over a 24 hour time period.  Samples were removed at selected time points 
and solvent-extracted α-tocopherol measured by HPLC analysis using the 
fluorescence detector with an excitation at 292 nm and an emission at 335 nm.   
 
Plasma incubated in the absence of 10 mM AAPH shows very little change in α-
tocopherol concentration with the concentration staying relatively constant over the 
24 hour incubation period (Figure 3.5.1).  The slight increase in α-tocopherol 
concentration within the first two hours of incubation is too small to be significant.  In 
the presence of AAPH, the concentration of α-tocopherol declines but this only begins 
after two hours.  By eight hours the AAPH-induced loss of α-tocopherol reaches a 
plateau, with a very small and insignificant decrease observed between eight and 24 
hours.   
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Figure 3.5.1 α-Tocopherol loss in plasma oxidized by the peroxyl radical initiator 
AAPH 
Plasma was incubated in the presence and absence of 10 mM AAPH at 37˚C.  The incubation 
was over a 24 hour period, with samples removed for analysis at selected time intervals.  α-
Tocopherol was measured by HPLC analysis, using the fluorescence detector with an 
excitation of 292 nm and an emission of 335 nm.  Each data point represents the mean ± SEM 
of triplicate samples. 
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3.5.2 α-Tocopherol concentration in dialysed plasma oxidized by 
AAPH 
 
To investigate the effect of plasma dialysis on α-tocopherol levels, dialysed plasma 
was incubated with 10 mM AAPH over a 24 hour period with α-tocopherol monitored 
by HPLC analysis.  Surprisingly, the α-tocopherol concentration started declining 
immediately and was completely depleted by eight hours (Figure 3.5.2).  This 
suggested that dialysis removed a small molecular weight molecule and that this 
molecule was responsible for protecting α-tocopherol from peroxyl radical attack.  An 
interaction between α-tocopherol and a soluble co-antioxidant has previously been 
described during studies using purified lipoprotein (Esterbauer et al., 1992).  This type 
of interaction could explain the source of the cholesterol diene lag phase.    
 
0 4 8 12 16 20 24
0
5
10
15
20
Time (Hour)
α -
To
co
ph
er
ol
 c
on
ce
nt
ra
tio
n 
(µ
M
)
 
Figure 3.5.2 α-Tocopherol concentration in dialysed plasma oxidized by the 
peroxyl radical initiator AAPH 
Dialysed plasma was incubated with 10 mM AAPH at 37˚C.  Incubation was over a 24 hour 
period, with samples removed for analysis at selected time intervals.  α-Tocopherol was 
measured by HPLC analysis, using the fluorescence detector with an excitation of 292 nm and 
an emission of 335 nm.  Each data point represents the mean ± SEM of triplicate samples. 
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3.5.3 Effect of ascorbic acid on α-tocopherol concentration in 
dialysed plasma oxidised by AAPH 
 
Due to the known ability of ascorbate to interact with the α-tocopherol radical and 
recycle the radical back to α-tocopherol (Mendiratta et al., 1997; Schafer et al., 2003; 
Retsky et al., 1993; Suh et al., 2003; Nieto et al., 2000; Gebicki et al., 2000b) the 
effect of supplemented ascorbate on plasma α-tocopherol levels was examined.  
Dialysed plasma was therefore, supplemented with ascorbic acid and incubated for 
one hour at 37˚C to allow time for equilibration.  The supplemented plasma was then 
incubated with 10 mM AAPH over a 24 hour time period and samples removed at 
selected time points for the measurement of  α-tocopherol by HPLC. 
  
When the dialysed plasma was supplemented with ascorbic acid, the slight but 
significant increase in α-tocopherol concentration within the first two hours of 
incubation was restored (Figure 3.5.3).  However, the concentration dropped 
dramatically after the two hours with complete depletion of α-tocopherol levels by ten 
hours.  This was two hours longer than in the dialysed plasma incubated with 10 mM 
AAPH, indicating that the ascorbic acid contributes to the protection of α-tocopherol 
in the first two hours of incubation, but does not reduce the radical flux post-lag 
phase.  This is further evidence of α-tocopherol and ascorbic acid interacting, thereby 
restoring the α-tocopherol levels for the period ascorbic acid is present in the plasma.  
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Figure 3.5.3 α-Tocopherol concentration in dialysed plasma, supplemented with 
ascorbic acid, and oxidized by the peroxyl radical initiator AAPH 
Dialysed plasma was supplemented with ascorbic acid and incubated with 10 mM AAPH at 
37˚C.  Incubation was over a 24 hour period, with samples removed for analysis at selected 
time intervals.  α-Tocopherol was measured by HPLC analysis, using the fluorescence 
detector with an excitation of 292 nm and an emission of 335 nm.  Each data point represents 
the mean ± SEM of triplicate samples. 
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3.5.4 Effect of uric acid on the α-tocopherol concentration in dialysed 
plasma oxidised by AAPH 
 
Uric acid, in combination with ascorbic acid has previously been shown to protect 
plasma proteins from peroxyl radical attack during the first six hours of incubation, 
producing a lag phase (Figure 3.3.2)  Uric acid also  appears to reduce the radical flux 
post-lag phase, lowering the rate of both PrOOH and cholesterol diene formation in 
plasma exposed to AAPH (Figures 3.3.2 and 3.4.5).  The preceding experiment 
(Figure 3.5.3) showed that ascorbic acid is only responsible for an initial two hour 
protection of α-tocopherol but not the rest of the 24 hours.  To investigate whether 
uric acid plays a role in sparing α-tocopherol directly or indirectly, dialysed plasma 
was supplemented with uric acid and incubated for one hour at 37˚C to allow 
equilibration.  The supplemented dialysed plasma was then incubated with 10 mM 
AAPH over a 24 hour period and samples were removed at selected time points to be 
measured for α-tocopherol by HPLC.  
 
AAPH-mediated α-tocopherol loss was significantly slower in dialysed plasma, 
supplemented with uric acid, than in dialysed but unsupplemented plasma (Figure 
3.5.4).  By eight hours, all α-tocopherol in the latter treatment.  Even after 24 hours, 
α-tocopherol in the dialysed supplemented plasma had not been completely depleted.  
The loss of α-tocopherol did, however occur at a slightly faster rate in this treatment 
than in the undialysed plasma.  Despite this, the above observations suggest that uric 
acid is able to protect α-tocopherol from attack by free radicals.   
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Figure 3.5.4 α-Tocopherol concentration in dialysed plasma supplemented with 
uric acid, and oxidized by the peroxyl radical initiator AAPH 
Dialysed plasma was supplemented with uric acid and incubated with 10 mM AAPH at 37˚C.  
Incubation was over a 24 hour period, with samples removed for analysis at selected time 
intervals.  α-Tocopherol was measured by HPLC analysis, using the fluorescence detector 
with an excitation of 292 nm and an emission of 335 nm.  Each data point represents the mean 
± SEM of triplicate samples. 
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3.5.5 Effect of uric acid and ascorbic acid together on the α-
tocopherol concentration in dialysed plasma oxidized by AAPH 
 
The finding that ascorbic acid protected α-tocopherol for the first two hours (Figure 
3.5.3) and uric acid slowed α-tocopherol loss over the 24 hours (Figure 3.5.4), 
suggested that both ascorbic acid and uric acid together may completely account for 
the protection of α-tocopherol.  To investigate this, dialysed plasma was 
supplemented with both ascorbic acid and uric acid and incubated for one hour at 
37˚C to allow the uric acid and ascorbic acid to equilibrate with the dialysed plasma.  
This dialysed and supplemented plasma was then incubated with 10 mM AAPH over 
a 24 hour period, with samples removed at selected time points to be measured for α-
tocopherol by HPLC. 
  
Dialysed plasma, supplemented with both ascorbic acid and uric acid, showed a 
protection of α-tocopherol so strong that these antioxidants almost completely 
restored α-tocopherol to the levels observed when undialysed plasma was incubated 
with 10 mM AAPH (Figure 3.5.5).   In fact, there was no statistical difference until 
the 24 hour time point.  The lack of statistical significance until 24 hours was 
previously noted when comparing PrOOH formation between undialysed plasma and 
dialysed plasma supplemented with both ascorbic and uric acid (Figure 3.3.2).   
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Figure 3.5.5 α-Tocopherol concentration in dialysed plasma supplemented with 
uric acid and ascorbic acid, and oxidized by the peroxyl radical initiator AAPH 
Dialysed plasma was supplemented with uric acid and ascorbic acid and incubated with 10 
mM AAPH at 37˚C.  Incubation was over a 24 hour period, with samples removed for 
analysis at selected time intervals.  α-Tocopherol was measured by HPLC analysis, using the 
fluorescence detector with an excitation of 292 nm and an emission of 335 nm.  Each data 
point represents the mean ± SEM of triplicate samples.  Significance shown for between 
treatments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
. 
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3.6 Protein-bound 3,4-dihydroroxyphenylalanine (PB-
DOPA) production on BSA 
 
3.6.1 PB-DOPA production on BSA exposed to X-ray radiolysis 
 
Protein-bound 3,4-dihydroroxyphenylalanine (PB-DOPA) is a major product of 
radical attack on tyrosine residues in peptides and proteins (Simpson et al., 1992; 
Gieseg et al., 1993).  X-rays are one way of producing radicals that oxidise the 
tyrosine residues on proteins to PB-DOPA.  A previous investigation by Parkes, 
(2005), using both HPLC analysis and the ED-DOPA assay, showed that the 
formation of PB-DOPA in BSA exposed to X-rays is linear and lacks a lag phase.  In 
order to reproduce the results observed by Parkes, (2005), BSA solutions in PBS were 
irradiated and exposed to a constant source of oxygen.  BSA solutions of 1 mg/ml and 
8 mg/ml of BSA solution were used by Parkes, (2005) to investigate the formation of 
PB-DOPA and both will be used in this study to determine which concentration 
permits the best detection of PB-DOPA.  BSA was placed in an X-ray machine 
(Philips model PW2264-20 tungsten x-ray generator, 35kV, 30mA) and exposed to a 
dose rate of 5.8 Gy/min, under constant oxygen bubbling, for 30 and 60 minutes.  
Samples were then analysed for PB-DOPA formation by HPLC analysis and the ED-
DOPA assay. 
 
Both 1 mg/ml and 8 mg/ml produced PB-DOPA in sufficient concentrations to be 
detected by both types of analysis (Figure 3.6.1).  In agreement with Parkes, (2005), 
the concentration of PB-DOPA increased as the length of irradiation increased and it 
did so in a linear fashion with no detectable lag phase.  Detection of PB-DOPA by the 
ED-DOPA assay gave an r2 value = 0.989 for 8 mg/ml BSA solution, while the 1 
mg/ml BSA solution had an r2 value = 0.993.  HPLC analysis gave an r2 value of 
0.882 for the 8 mg/ml BSA solution, while the 1 mg/ml BSA solution had an r2 value 
of 0.894.  ED-DOPA analysis detected a much higher concentration of DOPA than 
the HPLC analysis, 30 times higher for 1 mg/ml and 12.5 times higher for 8 mg/ml.   
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Figure 3.6.1 PB-DOPA production in irradiated BSA 
1 mg/ml and 8 mg/ml BSA were exposed to X-ray radiation.  Samples from 0, 30 and 60 
minutes of exposure were analysed by A) ED-DOPA and B) HPLC.  Time can be converted 
to dose rate using the dose rate of 5.8 Gy/min. Each data point represents the mean ± SEM of 
triplicate samples. 
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3.6.2 PB-DOPA production on BSA exposed to X-rays over a 60 
minute time period 
 
Although 1 mg/ml and 8 mg/ml BSA were both shown to be suitable concentrations 
for detecting PB-DOPA (Figure 3.6.1), additional experiments were conducted using 
only 1 mg/ml BSA.  Figure 3.6.1 did support the existence of a linear trend in 
irradiation-induced PB-DOPA formation on BSA, with a lack of detectable lag phase.  
However, very few sample time points were collected in that preliminary study.  PB-
DOPA formation during exposure to X-rays was therefore more thoroughly 
investigated in the additional experiments by sampling eight time points between zero 
and 60 minutes.  Furthermore, measuring PB-DOPA concurrently by both ED-DOPA 
and HPLC during these experiments enabled a correlation between the two assays to 
be drawn.  This is of interest because Parkes, (2005) and Figure 3.6.1 noted that PB-
DOPA values are higher when evaluated by ED-DOPA compared to HPLC.  BSA 
was therefore placed in eight labelled vials at a concentration of 1 mg/ml, and exposed 
to various radiation times between zero and 60 minutes before being analysed PB-
DOPA by both the ED-DOPA assay and HPLC analysis.   
 
The correlation between the ED-DOPA assay and HPLC analysis was high, with an r2 
value = 0.989 (Figure 3.6.2).  The line of best fit for these two assays yielded an 
equation of y=7.841x + 0.108.  Irradiation at selected time points over 60 minutes 
confirms more fully that the PB-DOPA concentration measured by both the ED-
DOPA assay and HPLC analysis increases in a linear fashion over time (Figure 3.6.3).  
However, the PB-DOPA measured by the ED-DOPA assay is almost eight times 
higher than the concentration measured by HPLC analysis at each corresponding 
irradiation time point.   
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Figure 3.6.2 Correlation between ED-DOPA assay and HPLC analysis 
The equation of this best fit line is y=7.84x + 0.108 with an r2 value = 0.989. 
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Figure 3.6.3 PB-DOPA production in irradiated BSA 
1 mg/ml BSA was exposed to radiation.  Samples were collected at selected exposure times, 
up to 60 minutes, and analysed for PB-DOPA formation by both the ED-DOPA assay and 
HPLC analysis. Time can be converted to dose rate using a dose rate of 5.8 Gy/min.  Each 
data point represents the mean ± SEM of triplicate samples. 
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3.6.3 PB-DOPA formation on BSA exposed to radicals produced by 
the Fenton reaction 
 
Oxidative damage is often related to the Fenton reaction, which is the one electron 
reduction of hydrogen peroxide (H2O2) by transition metal ions to produce the most 
reactive and damaging ROS, the hydroxyl radical (OH˙) (Reaction 21).  The resulting 
Fenton-derived radicals are thought to cause additional injury to the cell components 
especially proteins. 
 
                  (21)        Fe2+ + H2O2 --> Fe3+ + OH- +OH˙ 
 
Since oxidative damage can be initiated by the Fenton reaction, it has been proposed 
that exposing BSA to Fenton radicals may produce PB-DOPA.  This was investigated 
by Simpson and Dean (1990) and Gieseg et al. (1993), who found that PB-DOPA was 
indeed formed on BSA exposed to radicals derived from the Fenton reaction.  In order 
to reproduce the results of these previous investigations, 1 mg/ml of BSA was 
incubated with different concentrations of copper chloride and hydrogen peroxide for 
30 minutes at 37˚C.  Catalase was the added to stop the reaction and remove the 
hydrogen peroxide, followed by the addition of chelex to remove the free metal ions.  
Samples were analysed for PB-DOPA, using the ED-DOPA assay and HPLC 
analysis.   
 
In agreement with previous findings, significant concentrations of PB-DOPA were 
produced when BSA was exposed to radicals derived from the Fenton reaction 
(Figure 3.6.4).   Both the ED-DOPA assay and HPLC analysis show PB-DOPA 
formation increasing with increasing concentrations of copper in a linear fashion 
between 40 μM and 100 μM of copper.  The concentration of PB-DOPA was almost 
25 times higher, when measured by the ED-DOPA assay.  This, along with Figures 
3.6.1 and 3.6.3 indicate that the ED-DOPA assay is measuring PB-DOPA and its 
oxidation products while HPLC analysis detects only PB-DOPA.   
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Figure 3.6.4 PB-DOPA production on BSA exposed to copper chloride 
1mg/ml BSA was exposed to 0, 40, 70, and 100 μM of copper chloride and analysed for PB-
DOPA production by the A) ED-DOPA assay and B) HPLC analysis.  Time can be converted 
to dose rate using the dose rate of 5.8 Gy/min.  Each data point represents the mean ± SEM of 
triplicate samples. 
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3.6.4 Comparison of the techniques for detecting PB-DOPA: ED-
DOPA assay and HPLC analysis. 
 
Irrespective of the oxidation source, the ED-DOPA assay consistently detected higher 
concentrations of PB-DOPA than HPLC analysis.  This result indicates that the ED-
DOPA assay does not specifically measure PB-DOPA, but is measuring PB-DOPA 
oxidation products as well.  This can make results inaccurate and misleading, leading 
to false high readings of “PB-DOPA”.  Therefore, it was investigated to see if this 
higher concentration of PB-DOPA was correct or whether this ED-DOPA assay was 
indeed picking up other products and giving deceptive results of the concentration of 
PB-DOPA present.   
 
To investigate the inaccuracy of the ED-DOPA assay, BSA was dissolved at 1 mg/ml 
in unchelexed sodium phosphate buffer and exposed to X-rays under constant oxygen 
bubbling for 60 minutes.  110 μM copper sulphate was subsequently added to half the 
samples that had been irradiated for 60 minutes and half the samples that had not been 
exposed to radiation.  The remaining half of each time point (0 and 60 minutes) 
served as controls, with no copper sulphate added.  Catalase was added to all 
treatments to remove hydrogen peroxide and chelex was added to remove transition 
metals before analysing samples using the ED-DOPA assay and HPLC analysis. 
 
Incubating the irradiated BSA with copper sulfate promotes the oxidation of any PB-
DOPA that has formed.  The HPLC method is specific for PB-DOPA, not its 
oxidation products and as expected, this assay detected less PB-DOPA after treating 
the BSA with copper (Figure 3.6.5).  By contrast, the ED-DOPA assay is thought to 
measure both PB-DOPA and its oxidation products.  Indeed, after incubating 
irradiated BSA with copper an increase in “PB-DOPA” concentration was observed 
by the ED-DOPA assay.  From these results it can be concluded that the ED-DOPA 
assay does not present a representative concentration of PB-DOPA in samples.  The 
trend is accurate but the concentration is clearly not.  However, the correlation 
between the ED-DOPA assay and the HPLC PB-DOPA analysis is linear, producing 
and equation of y=7.841x + 0.108 (Figure 3.6.2).  The PB-DOPA detected by ED-
DOPA can therefore be easily converted to a more representative concentration.  
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Figure 3.6.5 PB-DOPA production on BSA exposed to copper sulfate  
1mg/ml BSA was exposed to radiation for 60 minutes and then incubated in the presence or 
absence of 110 μM copper sulphate. Samples were analysed for PB-DOPA production by the 
A) ED-DOPA assay and B) HPLC analysis.  Time can be converted to dose rate using the 
dose rate of 5.8 Gy/min.  Each data point represents the mean ± SEM of triplicate samples.  
Significance is between treatments. 
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DISCUSSION 
 
4.1 AAPH-mediated protein oxidation 
 
4.1.1 PrOOH formation on BSA  
 
When incubated at 37˚C under aerobic conditions, AAPH will decompose to release 
radicals at a relatively constant rate of 1.36 x 10-7 Ms-1 (Niki, 1995).  In a solution of 
BSA exposed to 10 mM AAPH, PrOOHs were found to form in a linear fashion with 
r2=0.9796 (Figure 3.1.1).  This shows that PrOOH are formed on pure proteins 
exposed to peroxyl radicals with no observable lag phase.  Using the rate of radical 
generation and the equation rate =2 x Kd x [AAPH], formation can be calculated at 
3.19 x 10-9 Ms-1.  This equates to be 13 PrOOHs generated for every 100 peroxyl 
radicals formed, and is comparable to previous work in the laboratory (Ling, 2004; 
Yang, 2005).   
 
4.1.2 Protein oxidation in human plasma exposed to peroxyl radicals 
 
AAPH-mediated PrOOH formation in plasma was associated with a six hour lag 
phase during which, very few PrOOHs were detected, followed by a rapid increase in 
PrOOH production and finally a plateau in PrOOH levels after 12 hours (Figure 
3.1.2).  This result was comparable to previous work in the laboratory (Ling, 2004; 
Yang, 2005).  PrOOH formation has been found to form on pure proteins and in 
plasma but, contradictory to the results observed in this study, PrOOH formation 
occurred immediately with no observable lag phase (Simpson et al., 1992; Gebicki et 
al., 2000a and b; Gieseg et al., 2000).  This may be due to these investigations using 
radiation-induced hydroxyl radicals to initiate PrOOH formation, whereas the current 
investigation uses less reactive peroxyl radicals.  Hydroxyl radicals are produced at a 
rate of 3.4 x 10-8 Ms-1 (Simpson et al., 1992), whereas peroxyl radicals are produced 
at a rate of 1.36 x 10-7 Ms-1 (Niki, 1995) suggesting hydroxyl radicals may have a 
faster reaction rate than peroxyl radicals in this study.  This may explain the 
immediate production of PrOOH in the presence of hydroxyl radicals compared to the 
peroxyl radicals used in this investigtion.  The lag phase observed when plasma is 
exposed to peroxyl radicals suggests that the protection of the plasma proteins is 
provided by the antioxidants present in human plasma.   
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4.1.3 Loss of PrOOH lag phase in dialysed plasma exposed to peroxyl 
radicals 
 
Plasma dialysis removes low molecular weight antioxidants while retaining larger 
molecules.  Dialysis of human plasma and then incubation with 10 mM AAPH 
produces PrOOHs immediately, with no six hour lag phase (Figure 3.1.3).  This result 
is comparable to that observed by Yang, (2005) and indicates that small molecular 
weight molecules protect the plasma proteins during the lag phase.  Although this 
eliminates protein thiols as the source of the lag phase, it was initially suggested that 
small molecular weight thiols like GSH could play a role in protecting the plasma 
proteins.  However, Yang, (2005) disproved this theory when dialysed plasma, 
supplemented with GSH, failed to restore the PrOOH lag phase during incubation 
with AAPH.  
 
4.2 Involvement of low molecular weight molecules 
involvement in the protection of plasma proteins 
 
4.2.1 The role of uric acid and ascorbic acid in preventing protein 
oxidation 
 
Yang, (2005) also supplemented dialysed plasma with uric acid or ascorbic acid.  
Under each of these conditions, the lag phase was partially restored, leading to the 
suggestion that uric acid and ascorbic acid might play a role in the six hour lag phase.  
To further investigate this, uric acid and ascorbic acid levels were monitored in 
undialysed plasma incubated with 10 mM AAPH (Figure 3.2.1).  As ascorbic acid is 
depleted within two hours of incubation this antioxidant cannot be solely responsible 
for the lag phase.  Nevertheless, the dramatic loss within two hours indicates it plays a 
role in protection.  Uric acid is lost slowly over time but 50% still remains after 24 
hours suggesting that, while uric acid may play a role during the lag phase, its 
antioxidant role during the rest of the oxidation period may be just as critical.  This 
may be important for the long term prevention of protein oxidation with PrOOH 
levels in dialysed plasma being twice as high as in undialysed plasma (Figure 3.1.1).  
It is possible uric acid scavenges free radicals limiting the oxidation of plasma 
proteins.   
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Further support for the contribution of uric acid and ascorbic acid to the lag phase 
arises from the observation that supplementation of dialysed plasma with both 
antioxidants concurrently reproduces the lag phase to what was detected in undialysed 
plasma incubated with 10 mM AAPH (Figure 3.3.2).  The supplemented dialysed 
plasma result matches the plasma result exactly until between the 12 and 24 hour time 
points.  After 12 hours, the plasma sample reaches a plateau whereas the dialysed 
plasma supplemented with the antioxidants continues to increase.  This may have 
been due to the supplemented uric acid being lost quicker and eventually being 
depleted by 12 hours compared to uric acid in undialysed plasma, which is not 
depleted during the incubation period.   Yang, (2005) finding a two hour lag phase 
was restored when dialysed plasma was supplemented with ascorbic acid, suggests the 
relative reactivity of ascorbic acid is greater than that of uric acid and as a result is 
responsible for protection during the first two hours of incubation.  Ascorbic acid is 
known to be the most effective antioxidant in plasma (Retsky et al., 1993) and can 
consume the peroxyl radicals produced by AAPH.  This transforms them to less 
potent forms, preventing protein attack and significantly reducing the production of 
PrOOHs (May et al., 1998).  Yang, (2005) also found a partial restoration of the lag 
phase when dialysed plasma was incubated with uric acid.  Although not a complete 
restoration of the observed lag phase, it did account for four of the six hours of 
protection.  This further supports the theory that uric acid is protecting the plasma 
proteins once ascorbic acid is depleted.  The reduction in PrOOH concentration when 
uric acid is present in the plasma compared to the concentration found in dialysed 
plasma indeed indicates uric acid is reducing the radical flux not only for the six hour 
lag phase but also for the incubation period.   
 
To further investigate the role of uric acid in the six hour lag phase, undialysed 
plasma was supplemented with excess uric acid.  This supplementation doubled the 
uric acid concentration in the plasma and was hypothesised to extend the lag phase.  
As expected, the lag phase was indeed extended from six hours to 12 hours (Figure 
3.3.4) indicating uric acid plays a vital role in protecting the plasma proteins during 
the lag phase and reducing the overall radical flux during the incubation period once 
ascorbic acid had been consumed. 
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Furthermore, incubating undialysed plasma with uricase was expected to remove uric 
acid from the plasma and therefore remove all but two hours of the lag phase.  Uricase 
is an enzyme that breaks uric acid down to allantoin, carbon dioxide and hydrogen 
peroxide.  Unexpectedly the lag phase during AAPH-mediated oxidation was not 
eliminated (Figure 3.3.3) with six hours of lag observed.  This in contrast to what has 
been observed in prior experiments supplementing dialysed plasma with uric acid 
(Figure 3.3.2), and adding excess uric acid to plasma (Figure 3.3.4).  The result was so 
similar to control plasma incubated with AAPH, that at first it appeared as though the 
uricase had no effect.  However, upon closer inspection, it was noted that PrOOH 
formation after the six hour lag phase occurred at a faster rate in the uricase-treated 
plasma than in the control.  This increased rate resulted in almost twice the 
concentration of PrOOHs by eight hours compared to the control, confirming that 
uricase was removing uric acid from the undialysed plasma.  It is contradictory to the 
previous results which showed a return of the lag phase (Figure 3.3.2) when dialysed 
plasma was supplemented with ascorbic acid and uric acid and an extended lag phase 
when excess uric acid was added to undialysed plasma (Figure 3.3.4).  It could be that 
the uric acid break down product, allantoin, exhibits antioxidant activity by 
scavenging radicals and providing the same effect as uric acid.  In addition, maybe 
this scavenging activity ultimately converts allantoin back to uric acid.  Patterson et 
al. (2003) also used uricase to removed uric acid from plasma finding the degradation 
of uric acid by uricase, removed the protection effect suggesting uric acid was the 
major antioxidant in the ultra filtrate of plasma.  This is contradictory to the results 
observed here as no effect on protection of plasma proteins was observed when uric 
acid was broken down. 
 
4.2.2 Free amino acids as antioxidants in human plasma 
 
Free amino acids in the plasma are also thought to be capable of protecting plasma 
proteins as they are small enough to be removed by dialysis and are present in 
sufficient concentrations.  To investigate this further, dialysed plasma was 
supplemented with 250 μM and 500 μM of the free amino acids valine, alanine, 
glutamine, lysine and glysine (Figures 3.3.1A and B).  These are the amino acids of 
highest concentration found in plasma but yet did not show any significant difference 
from control plasma incubated with AAPH.  This suggests that the five most 
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commonly identified amino acids in plasma are not acting as sacrificial antioxidants 
protecting plasma proteins under the conditions of this study.  To further investigate 
the result observed in Figures 3.3.1A and B, the six amino acids found to be the most 
vulnerable to free radical attack, tyrosine, proline, leucine, isoleucine, arginine and 
histidine, were supplemented to dialysed plasma  but also failed to restore the six hour 
lag phase (Figure 3.3.1C).  In light of these results it can be concluded that free amino 
acids in the plasma, both the highest concentration and the most reactive with free 
radicals, do not contribute to the protection of plasma proteins during the first six 
hours of incubation with AAPH.  Uric acid and ascorbic acid are clearly more reactive 
towards peroxyl radicals than free amino acids when supplemented at the 
concentrations described in this study. 
 
4.3 Effect of peroxyl radical attack on lipids in human blood 
plasma 
 
The kinetics of AAPH-induced lipid oxidation are described by a two hour lag phase 
in cholesterol diene formation followed by a rapid linear increase for the rest of the 24 
hour period (Figure 4.4.1).  This is in contrast with the lack of cholesterol diene 
formation in plasma incubated in the absence 10 mM AAPH and confirms that the 
increase due to peroxyl radical attack is not auto-oxidation of the plasma lipids.  The 
result further indicates that an unidentified antioxidant is inhibiting lipid oxidation 
during the first two hours of incubation with peroxyl radicals but, upon depletion of 
this substance lipid oxidation proceeds.  Lipid peroxidation in human blood plasma 
exposed to peroxyl radicals has been previously investigated by other groups and is in 
agreement with the results observed here.  In these studies a lag phase during which 
no or very few lipid hydroperoxides formed was observed over the first 50-60 minutes 
(Thomas et al., 1997; Neuzil et al., 1994; Frei et al 1988).  The kinetics of lipid 
oxidation in a pure lipoprotein solution are also described by a lag, propagation and 
decomposition phase (Esterbauer et al., 1989).  However, the end of the lag phase was 
observed to coincide with the complete consumption of α-tocopherol in this system.  
The results in this investigation show the depletion of ascorbic acid coincides with the 
end of the two hour lipid peroxidation lag phase (Figure 3.2.1).  Also coinciding with 
the end of the lag phase in LDL is the end of the PrOOH lag phase (Gieseg et al., 
2003).  The continued close linkage between lipid peroxidation and protein 
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peroxidation throughout the propagation and decomposition phases of LDL oxidation 
has led to the suggestion that PrOOHs are formed from a lipid-derived radical.   
Comparing the kinetics of lipid and protein oxidation in Figure 3.3.1 at first showed 
no connection between the two processes.   
 
4.3.1 Role of uric acid and ascorbic acid in reducing lipid oxidation in 
human plasma 
 
The results found in this investigation indicate ascorbic acid and uric acid protect 
plasma lipids in plasma exposed to peroxyl radicals (Figure 3.4.6).  Supplementation 
of dialysed plasma with both antioxidants concurrently showed a return of the two 
hour lag phase and an overall reduction in cholesterol diene concentration to that 
observed in the undialysed and unsupplemented plasma.  The results indicate that 
ascorbic acid is responsible for the two hour lag phase by inhibiting lipid oxidation 
while present in the plasma, as the two hour lag phase returned when dialysed plasma 
was supplemented with ascorbic acid (Figure 3.4.4).  There was no reduction in the 
cholesterol diene concentration after the two hours.  Alternatively, ascorbic acid could 
be acting as a co-antioxidant for α-tocopherol.  This type of role has been described 
for ascorbic acid (Mendiratta et al., 1997; Schafer et al., 2003; Retsky et al., 1993; 
Suh et al., 2003; Nieto et al., 2000; Gebicki et al., 2000b).  By reacting with the α-
tocopheroxyl radical ascorbic acid can regenerate α-tocopherol and export the radical 
from within the oxidising lipid particles to the aqueous phase.  The regenerated α-
tocopherol molecule can meanwhile continue inhibiting lipid oxidation.  Once the 
ascorbic acid is depleted the α-tocopherol can no longer be regenerated.  Under these 
conditions of low radical flux, this reaction results in the induction of α-tocopherol’s 
pro-oxidant activity and therefore lipid oxidation. 
  
After the depletion of ascorbic acid, uric acid then becomes the main antioxidant and 
appears to do so by reducing the overall radical flux.   The general ability of uric acid 
to reduce the radical flux explains why it effectively reduces the rate of both PrOOH 
and cholesterol diene formation.  Uric acid’s role in reducing the overall radical flux 
for the incubation period is confirmed in Figure 3.4.5 where there is an observable 
reduction in cholesterol diene concentration over the incubation period in dialysed 
plasma supplemented with uric acid compared to control unsupplemented dialysed 
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plasma.  The concentration was reduced almost to the level observed in oxidised 
plasma.  Uric acid is described as an excellent scavenger of peroxyl radicals but is 
unable to prevent lipid oxidation agreeing with the results observed in this study (Frei 
et al., 1989; Stocker et al., 1991; May, 1998; Suara et al., 1995; Nieto et al., 2000; 
Frei et al., 1988; Ames et al., 1981).  Gebicki et al. 2000a removed ascorbic acid and 
uric acid from the plasma by dialysis and found that lipid peroxides in the resulting 
plasma formed immediately upon exposure to radiation.  However, it is not in 
agreement with Esterbauer et al, (1989), finding uric acid added to isolated LDL 
increased the lag phase of lipid oxidation where no oxidation occurred.  This 
investigation was carried out on isolated LDL indicating the reaction may be faster 
enabling uric acid to inhibit lipid oxidation.   
 
4.4 α-Tocopherol (Vitamin E) loss in AAPH-induced plasma 
oxidation 
 
α-Tocopherol (α-TOH) is the major lipid soluble antioxidant in LDL (Terentis et al., 
2002).  It is thought to protect LDL against lipid peroxidation by directly scavenging 
free radicals and reacting rapidly with chain-carrying lipid peroxyl radicals (LOO˙) to 
break propagation (Kontush et al., 1996; Niki et al., 2005; Thomas and Stocker, 2000; 
Bowry et al., 1992).  In the absence of AAPH, the α-tocopherol concentration remains 
relatively constant during the 24 hour incubation period (Figure 3.5.1).  In the 
presence of AAPH, the α-tocopherol level is unchanged for the first two hours, but 
this is followed by a decrease between two and eight hours and plateaus from ten 
hours onwards (Figure 3.5.1).  This result agrees with a study by Ling, (2004) and 
suggests that the α-tocopherol was being consumed while protecting the plasma lipids 
from oxidation by its chain-breaking antioxidant activity.   
 
4.4.1 The ability of uric acid and ascorbic acid to protect α-
tocopherol from free radical attack in human plasma 
 
The results found in this investigation indicate that ascorbic acid and uric acid protect 
the α-tocopherol levels in plasma exposed to peroxyl radicals (Figure 3.5.5).  It can 
also be concluded that in the absence of ascorbic acid, α-tocopherol acts via TMP.  It 
switches from an antioxidant to pro-oxidant state, with the α-tocopheroxyl radical 
replacing the lipid peroxyl radical as the species initiating lipid oxidation.  It contrasts, 
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however with Yeum et al, (2003), who indicated α-tocopherol was the first line of 
defence against oxidative damage and uric acid the second.   The concentration of 
AAPH was double that used in this investigation suggesting the faster reaction was 
the cause for this.  Other laboratories investigating α-tocopherol’s role in the 
protection of lipid oxidation have drawn similar conclusions (Stocker, 1999; Upston 
et al., 1999; Thomas et al., 1997).  The TMP theory is further supported by the loss of 
α-tocopherol after eight hours of incubation when dialysed plasma is exposed to 
peroxyl radicals (Figure 3.5.2).  This depletion coincides with a 50% reduction in the 
rate of cholesterol diene formation and supports the theory that, in the absence of a 
co-antioxidant, α-tocopherol drives lipid peroxidation.  This pro-oxidant activity is in 
agreement with Bowry et al, (1992), and Neuzil and Stocker, (1994) also finding that 
α-tocopherol gave a pro-oxidant effect when both isolated LDL and plasma are 
oxidised by peroxyl radicals.  Peroxidation was faster in the presence of α-tocopherol 
so, as α-tocopherol was consumed, peroxidation declined.  Additional evidence for 
TMP arises from the fact that supplementation of dialysed plasma with ascorbic acid 
delays the loss of α-tocopherol for two hours (Figure 3.5.3).  This result highlights the 
ability of ascorbic acid to serve as a co-antioxidant by recycling the α-tocopheroxyl 
radical back to α-tocopherol.  While ascorbic acid is present in the plasma, the 
depletion of α-tocopherol inhibited.  After ascorbic acid is depleted from the plasma, 
the protection of α-tocopherol is by uric acid (Figure 3.5.4).  Uric acid is reducing the 
overall radical flux to α-tocopherol and therefore delaying the depletion of the 
antioxidant.  It is not a co-antioxidant for α-tocopherol, as it is unable to recycle the α-
tocopheroxyl radical back to α-tocopherol.  As discussed earlier, uric acid is unable to 
trap and remove radicals like ascorbic acid.  Instead, it scavenges the peroxyl radicals, 
and by doing so, intercepts the oxidation chain reaction (Frei et al., 1989; Thomas et 
al., 1997).   
 
4.5 Protein-bound 3,4-dihydroroxyphenylalanine (PB-
DOPA) production on BSA irradiated by x-rays 
 
4.5.1 PB-DOPA production on irradiated BSA 
 
Protein-bound 3,4-dihydroroxyphenylalanine (PB-DOPA) is a major product of 
radical attack on tyrosine residues in peptides and proteins.  Its formation has been 
studied by several other laboratories, who noted its production in a range of oxidising 
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systems and on a variety of substrates (Fu et al., 1998; Gieseg et al., 1993; Sutherland 
et al., 2003).  These radicals are generated by metal-catalysed Fenton systems, gamma 
radiation and UV light.   
 
The current study has confirmed once again the formation of PB-DOPA on BSA 
exposed to both irradiation and the Fenton system.  In the case of the former, PB-
DOPA was produced in a linear fashion during a 60 minute exposure to X-ray 
radiolysis (Figures 3.6.1 and 3.6.3).  The lack of a lag phase indicates that a certain 
concentration of radicals does not have to be generated before PB-DOPA is produced, 
it is formed as soon as the radicals are created.  It also suggests that BSA is very 
susceptible to PB-DOPA formation.  These results are in agreement with Parkes, 
(2005) who also observed a linear formation of PB-DOPA on BSA during radiolysis.  
Sutherland et al. (2003) also found that with increasing amounts of irradiated BSA, 
PB-DOPA formation increased linearly. 
 
The Fenton system also generates radicals that are capable of reacting with proteins to 
form PB-DOPA.  This confirms the results originally noted by Simpson and Dean 
(1990), and Gieseg et al. (1993) and has now been confirmed in the current study 
(Figure 3.6.4).  This indicates that during the Fenton reaction the radicals produced 
are capable of reacting with proteins to form reaction products, in this case PB-
DOPA.  The results also show that copper is capable of being the transition metal ion 
producing free radicals via the Fenton reaction.  Ranges of copper concentrations 
were investigated and all were shown to promote PB-DOPA formation on BSA by 
both assays.  Both the ED-DOPA assay and HPLC analysis detected PB-DOPA, with 
the ED-DOPA assay detecting a much higher concentration of DOPA than HPLC 
analysis.  This is also suggesting what was observed in Figures 3.6.1, 3.6.3, and 3.6.4 
that the ED-DOPA assay is measuring the oxidation products of PB-DOPA as well as 
PB-DOPA produced in the investigation.  Although the PB-DOPA concentration 
determined by each assay is significantly different, the two assays remain highly 
correlated with and r2=0.989 (Figure 3.6.2).   
 
 
 
 
 
Chapter 4 81
4.6 Specificity of the ED-DOPA assay 
 
Throughout the fluorometric research of PB-DOPA formation on BSA, two assays 
were always used.  One measures PB-DOPA by HPLC analysis of acid hydrolysates 
while the other measures PB-DOPA by fluorometric analysis.  PB-DOPA was found 
to be present at consistently higher concentrations when measured by the ED-DOPA 
assay compared to HPLC analysis.  This trend was observed when oxidation was from 
exposure to X-ray radiolysis (Figures 3.6.1 and 3.6.3) or the Fenton reaction (Figure 
3.6.4).  An experiment was therefore undertaken to determine whether the ED-DOPA 
assay was actually specific for PB-DOPA and the results were compared to HPLC 
analysis (Figure 3.6.5).  If both systems for measuring PB-DOPA were specific, a 
decrease in PB-DOPA concentration should have been observed when irradiated BSA 
was subsequently incubated with copper sulfate compared to the concentration 
observed in the control, irradiated BSA incubated in the absence of copper sulfate.  
Incubating with copper sulfate promotes the oxidation of any PB-DOPA that has 
formed, so if oxidation products are being detected in the assay, a higher 
concentration will be observed.  As expected, HLPC analysis of PB-DOPA showed a 
decrease in PB-DOPA concentration under these conditions.  By contrast, the ED-
DOPA assay showed a higher concentration than the control despite being treated 
identically to the HPLC samples.  Ethylenediamine reacts with o-diphenols to form a 
fluorescent derivative, which is measured at an excitation of 430 nm and an emission 
of 545 nm.  This result suggests that PB-DOPA is not the only o-diphenol able to 
react with ehtylenediamine, illustrating that the ED assay is detecting oxidation 
products of PB-DOPA in addition to the PB-DOPA itself.  The oxidation products are 
probably what the ED-DOPA assay is detecting as well as the PB-DOPA in the 
sample.  The assay may also be detecting other oxidized amino acids, particularly 
tryptophan and phenylalanine.   
 
It can be suggested from these results that the ED-DOPA assay cannot be solely used 
for measuring PB-DOPA as other products may be measured along with PB-DOPA.  
The HPLC analysis of PB-DOPA is a more accurate measurement of PB-DOPA as it 
measures only PB-DOPA and not its oxidation products or other oxidised amino 
acids.  Despite this, the ED-DOPA assay may still be useful.  It is cheaper and less 
time consuming than the HPLC method.  Accurate PB-DOPA measurements can be 
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derived from ED-DOPA reading because the concentrations of PB-DOPA detected by 
HPLC and ED-DOPA are highly correlated.  When a standard curve was created, 
using concentrations obtained during the irradiated BSA (Figure 3.6.2), a linear trend 
was observed (r2=0.989).  With HPLC and ED-DOPA measurements recorded on the 
x and y axes, respectively, an equation could be derived from this linear trend: 
y=7.84x + 0.11.  Any concentration recorded by the ED-DOPA assay can be 
converted to a more accurate concentration that is more representative of the PB-
DOPA concentration that would be detected by the HPLC analysis.  
 
4.7 Summary 
 
In this study, the kinetics of plasma protein and lipid oxidation were investigated in 
the presence of the peroxyl radical generator, AAPH.  PrOOH formation on plasma 
proteins and cholesterol diene formation on plasma lipids were associated with lag 
phases of six and two hours respectively.  During these lag phases, very little 
oxidation was detected but was followed by a rapid increase in PrOOHs and 
cholesterol dienes formation.  The different lengths of the lag phases meant that, 
initially the two processes did not appear to be related.  However, further investigation 
illustrated that the antioxidants, ascorbic acid and uric acid, were responsible for both 
lag phases and also for the reduction in overall radical flux throughout the incubation 
period.  Uric acid in particular, accounts for this latter activity.  It can be concluded 
that ascorbic acid is protecting the target molecules in the plasma during the two 
hours of oxidation as during the first two hours it is depleted from the plasma.  With 
lipid oxidation there is no cholesterol diene formation during the two hour lag phase 
indicating ascorbic acid is recycling the α-tocopheroxyl radical back to α-tocopherol 
to inhibit lipid oxidation during this period.  Protein oxidation however, is not 
inhibited by ascorbic acid during the lag phase, the PrOOH formation is significantly 
reduced during this period.  Ascorbic acid and uric acid not only protect plasma 
proteins and lipids from oxidative attack, but also protect α-tocopherol from being 
consumed.  It can be concluded that in the absence of the co-antioxidant ascorbic acid, 
α-tocopherol exhibits TMP activity.  In this pro-oxidant state, the α-tocopheroxyl 
radical is not recycled back to α-tocopherol, but instead replaces the lipid peroxyl 
radical as the species that initiates lipid oxidation.   
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The overall radical flux over the incubation period is being reduced by uric acid to 
delay the consumption of α-tocopherol.  Overall, it can therefore be concluded that the 
antioxidants, ascorbic acid and uric acid, play a pivotal role in the protection of 
plasma proteins, lipids and α-tocopherol from peroxyl radical attack. 
  
In a separate study, it was confirmed that PB-DOPA is formed on BSA during 
exposure to X-rays radiolysis and Fenton reagents.  Although both HPLC analysis and 
the ED-DOPA assay detected PB-DOPA in these systems, it can be concluded that the 
ED-DOPA assay is not sufficiently specific to enable the concentration of PB-DOPA 
to be accurately determined.  Compared to the HPLC analysis, ED-DOPA 
measurements are always significantly larger.  Additional experiments indicated that 
the ED-DOPA assay measures both PB-DOPA and its oxidation products, therefore 
accounting for the larger readings when using this assay.  By contrast, the HPLC 
analysis of acid hydrolysates only detects PB-DOPA and so, is a much more reliable 
assay as it only measures PB-DOPA.  
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